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SUMMARY ii
SUMMARY
1. The aims of this study were twofold. First to try to detect the non- 
adrenergic non-cholinergic ( NANC ) neurotransmitter in the bovine retrac­
tor penis by bioassay and secondly to study the effects of various drugs 
which might reveal its relationship with nitric oxide and endothelium- 
derived relaxing factor ( EDRF ). This second objective was pursued in 
both the bovine retractor penis and rat anococcygeus muscles.
2. The attempt to detect the NANC inhibitory neurotransmitter released by 
field stimulation from the donor bovine retractor penis muscle and detected 
by a variety of test tissues ( bovine retractor penis, rat anococcygeus and 
rabbit aortic strip ) arranged in several different test systems failed.
3. Superoxide dismutase ( 10 u./ml. up to 400 u./ml. ) had no effect on NANC 
inhibitory relaxation and had no measurable effect in protecting the NANC 
neurotransmitter.
4. L-Arginine, a precursor of EDRF, did not potentiate NANC inhibitory 
relaxation in the BRP either fresh or cold stored up to ten days.
5. L-Monomethyl-N-arginine ( L-NMMA, a competitive inhibitor of L- 
arginine in endothelial cells ) and D-monomethyl-N-arginine ( D-NMMA ) 
up to 3x1 O^M. were without effect on NANC inhibitory relaxation of the
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bovine retractor penis muscle. But at higher concentration of 10-3M. L- 
NMMA inhibited the NANC relaxation and further raised guanethidine- 
induced tone, an effect partially reversed by L-arginine 10-3M.
6. L-NMMA ( 10~5M. up to 3x10“^ .  ), but not D-NMMA ( 10_5M. up to 
SxiO^M. ), raised tone and inhibited the NANC inhibitory relaxation on the 
rat anococcygeus muscle in a dose-dependent manner, an effect competi­
tively reversed by L-arginine ( 3xlO-5M. up to 1(T3M. ) or by washing out 
the L-NMMA.
7. L-NMMA up to 6xlO^M. was without effect on the relaxation induced by 
nitric oxide on the rat anococcygeus or the rabbit aortic preparations sug­
gesting the inhibition of the response to nerve stimulation was not post- 
synaptic.
8. L-NMMA, but not D-NMMA, dose-dependently ( 10-5M. up to 3xiO"^M. ) 
inhibited the EDRF relaxation induced by acetylcholine in the rabbit aortic 
preparations, an effect reversed by L-arginine or washing out L-NMMA.
9. L-Canavanine, an inhibitor of nitric oxide production in macrophages, at 
concentration up to 3x10"^. had no effect on NANC relaxation of the BRP 
preparation. But at higher concentration of 10_3M. it inhibited the NANC 
relaxation, an effect partially reversed by L-arginine 10_3M.
10. L-Canavanine up to 2xlO_3M. exhibited no effect on NANC inhibitory relax­
ation on the rat anococcygeus preparation.
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INTRODUCTION 1
INTRODUCTION
Body function is controlled and integrated mainly by the nervous system and the 
endocrine system. The control in the nervous system depends primarily on the 
rapid electrical transmission of information in the nerve fibres, then between the 
nerve cells, and finally between the axone terminal of the last neurone in the 
chain and the effector and their cells it innervates. The signals across junctions 
are usually carried by chemical rather than electrical impulses. This chemical 
transmission takes place through the release of small amount of neurotransmitter 
from the nervous fibre terminals into the region of the synapse or junction. The 
chemical neurotransmitter diffuses to the postsynaptic cell and binds to a special­
ized receptor. The nerve system can be divided into two major functional subdi­
visions, the autonomic division and the somatic division. The autonomic nervous 
system in turn consists of two major portions, the sympathetic division and the 
parasympathetic division, originally based on anatomical differences. On the 
other hand, a different classification of the autonomic nervous system can be 
made, based on the neurotransmitter released from the nervous fibre terminals. 
Classically the autonomic nervous system consisted of a cholinergic nerve divi­
sion and a noradrenergic division, based on the release of either acetylcholine or 
noradrenaline. With only a few exception the cholinergic system corresponds to 
the parasympathetic division and the noradrenergic with the sympathetic division 
( Dale & Gaddum 1930; Dale 1935; Dale & Feldberg 1936 ). Modem scientific 
developments in biochemistry, physiology and pharmacology however have pro­
vided the evidence for the existences or coexistences of many other neuro­
transmitters i.e. a variety of peptidergic neurotransmitters as substance P,
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purinergic neurotransmitter by ATP and dopaminergic neurotransmitter. These 
have broken down the classical concept the autonomic nervous system only con­
sisted of cholinergic nerve and noradrenergic nerve.
Part of the evidence for the existence of these other neurotransmitters was a 
nerve response which was unaffected by either adrenergic or cholinergic block­
ing agents. Such responses and the nerves producing them are referred to as 
non-adrenergic non-cholinergic ( NANC ) responses and nerves. The non- 
adrenergic non-cholinergic nerve innervation exists broadly in most peripheral 
smooth muscles, largely in gastrointestinal tract, cardiovascular system, urinary 
reproductive system and glands. The NANC nerve innervation on bovine retrac­
tor penis muscle and rat anococcygeus muscle are the good examples. In 1972, 
Gillespie first reported that ■ the rat anococcygeus muscle appeared to possess 
many of the desirable features of an ideal innervated preparation of smooth mus­
cle for both pharmacological and physiological study. A dense adrenergic inner­
vation is distributed throughout the whole muscle and an NANC inhibitory inner­
vation originating in the sacral cord several spinal segments from the sym­
pathetic outflow was also discovered ( Gillespie 1972; Gillespie & McGrath 
1973 ). These inhibitory nerves were not an example of cotransmission by adren­
ergic nerves since destruction of the latter by 6-hydroxydopamine had no effect 
on the NANC inhibitory response ( Gibson & Gillespie 1973 ). In 1974 Klinge 
& Sjostrand reported a similar NANC inhibitory innervation in the bovine retrac­
tor penis muscle ( a continuation of the anococcygeus muscle, Gillespie & Mar­
tin 1980 ). In the BRP excitatory fibres derives from the lumber sympathetic 
outflow. Most fibres emanate from the sacral ganglia of the sympathetic chain 
and reach the muscle via the pudic nerve. Some fibres seem to run in the hypo­
gastric nerve and a few fibres may follow the pelvic parasympathetic nerves. The
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excitatory neurotransmitter of the sympathetic fibres in both muscles is noradre­
naline. The neurotransmitter of NANC inhibitory nerves in both tissues remains 
unknown. The requirements for a substance to be a neurotransmitter should be 
first it is present in the nerve fibres, secondly it is released by nerve stimulation, 
thirdly it should mimic the nerve response to electrical stimulation, drugs which 
potentiate or block the nerve response should have the same effect on the puta­
tive neurotransmitter, the mode of action of neurotransmitter of nerve should be 
the same, and finally combines with its receptor specifically. The rat anococ­
cygeus is a particularly significant tissue in deciding an possible candidates as 
NANC neurotransmitter since few potential candidates can cause relaxation in 
this tissue. The most obvious example is that while noradrenaline cause contrac­
tion through a-adrenoceptors so too does acetylcholine acting through conven­
tional muscarinic receptors. A cholinergic innervation is therefore ruled out. 
Isoprenaline fails to cause relaxation and at high doses it will cause contraction 
through a-receptor. A neurotransmitter acting through p-receptor ( which 
appears to be lacking in this species ) is also excluded. For similar reasons his­
tamine, 5-HT , dopamine, glycine, glutamate, ATP and a variety of peptides can 
be excluded. Only bradykinin and some related peptides and VIP cause relaxa­
tion at low doses. However, drugs such as haemoglobin and ethonal which are 
known to block the response to NANC nerve stimulation do not block the 
response to these peptides ( Gillespie et al. 1981a; Bowman et al. 1982b ). Only 
three potential candidates cause relaxation, act through a similar mechanism and 
are blocked by haemoglobin, there are nitric oxide ( NO ), the endothelium- 
derived relaxing factor ( EDRF ) and an inhibitory factor ( IF ) extracted from 
the BRP.
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HISTORICAL REVIEW OF NANC NERVE INNERVATION
In 1883 Sertoli first studied the retractor penis muscle of several species both in 
vitro and in vivo. He found the muscle exhibited spontaneous activity. When 
the muscle was electrically stimulated, it produced contraction and also some­
times relaxation. In warm environment it relaxed and in cold contracted. De 
Zilwa ( 1901 ) studied the dog retractor penis in vitro. He also found that the 
smooth muscle exhibited spontaneous activity and the tone increased in low but 
decreased in high temperature. The muscle stimulated electrically produced con­
traction when it was in low tone but relaxation in high tone.
Langley and Anderson ( 1895 ) reported that in rabbit atropine could not inhibit 
the penile erection produced by electrical stimulation of the sacral parasym­
pathetic outflow via the pelvic nerves. Bayliss and Starling ( 1899 ) reported 
that vagal stimulation in the dog small intestine caused first relaxation and then a 
following powerful contraction. Both the relaxation and the contraction were 
unaffected by atropine. Henderson and Roepke ( 1933 ), using penile perfusion 
in dog, found physostigmine potentiated the effect of pelvic nerve stimulation on 
venous flow, while atropine had almost no effect. In 1934 they also reported 
that in the guinea pig the motor response of the urinary bladder to parasym­
pathetic nerve stimulation was slightly reduced by low doses of atropine but the 
large residual motor effect was insensitive to even high doses. Oppenheimer ( 
1938 ) studied the cat retractor penis in vivo. He found the inhibitory frequency- 
response curve to parasympathetic stimulation was also hyperbolic. Acetylcholine 
mimicked the effect of this parasympathetic stimulation. Atropine abolished the 
effect of acetylcholine but not that of the parasympathetic stimulation. He 
believed the relaxation of the retractor penis was caused by the release of the
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neurotransmitter acetylcholine. The resistance to atropine of the parasympathetic 
response was due to the proximity theory, the theory of Dale and Gaddum ( 
1930 ) and reinvoked by Ambache ( 1955 ). The proximity theory was that the 
muscle cell membrane is in such close proximity to the nerve terminals as to 
deny access to exogenous blocking agents. Electron-microscopical studies 
disproved this theory because large gaps was found between the nerve terminal 
and the muscular cell membrane where neurotransmitter was released and acted 
on the target membrane. Goldenberg ( 1965 ) found that in cat retractor penis 
injected nicotine produced relaxation which was blocked by hexamethonium but 
not by atropine. He believed the relaxation was not due to acetylcholine but due 
to an unknown neurotransmitter released from the parasympathetic nerves stimu­
lated by nicotine. Henderson and Roepke ( 1934 ) from their work on the 
bladder also suggested that atropine resistance could be best explained by the 
major release of a neurotransmitter other than acetylcholine or noradrenaline.
The experimental proof of the existence of NANC nerves were delayed because 
no selective powerful adrenergic blocking drugs was available. When adrenergic 
neurone blocking drugs were introduced and applied to analyse the response of 
stomach to nerve stimulation, it was found they had no effect on the inhibitory 
response to vagal stimulation in the guinea pig stomach ( Martinson et al. 1963 ) 
and to transmural stimulation in the guinea pig and mouse ( Paton & Vane 1963 
). Non-adrenergic inhibitory nerves were suggested based on the observation 
that the nerve stimulation of the guinea pig taenia coli exhibited a potent inhibi­
tory response which was not blocked by bretylium ( Bumstock et al. 1963; 1964 
). Since then non-adrenergic inhibitory nerves have been reported in the stomach 
( Martinson 1965; Campbell 1966 ), the small intestine ( Holman & Hughes 
1965; Day & Warren 1967; 1968; Weston 1971; Hirst & McKirdy 1974 ) and
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the large intestine ( Bianchi et al. 1968; Small 1972 ).
Luduena and Grigas ( 1966 ) studied the pharmacology of the isolated dog 
retractor penis by field stimulation. They reported the response of field stimula­
tion on the untreated muscle was contraction which was blocked by phentolam- 
ine, piperoxan, bretylium, guanethidine and local anaesthetics. Bretylium and 
guanethidine also gradually induced a developing contraction and then the stimu­
lation of the muscle exhibited an inhibitory relaxation which was neither abol­
ished by atropine or scopolamine nor potentiated by physostigmine. Hemicho- 
linium, hexamethonium and dichlorosoproterenol ( DC1 ) had no effect on the 
inhibitory relaxation. Acetylcholine, histamine, nicotine and 5-hytroxytryptamine 
contracted the muscle. The muscular contraction induced by acetylcholine or 
nicotine was abolished by atropine or hexamethonium respectively. These might 
suggest an non-cholinergic innervation in the dog retractor penis. There was no 
evidence for the link between cholinergic and adrenergic neurotransmitters. 
They believed either excitatory sympathetic or inhibitory parasympathetic post­
ganglionic fibres were activated by field stimulation.
Klinge ( 1970a ) studied the response of the isolated bull retractor penis muscle 
to drugs. Adrenaline and noradrenaline at low concentrations produced vigorous 
muscular contraction which was abolished by phenoxybenxamine. Bradykinin at 
very low concentration contracted the muscle. Acetylcholine, histamine and 5- 
hytroxytryptamine also contracted the muscle but acetylcholine at high concen­
trations irregularly contracted the muscle. The muscle also exhibited contraction 
to a variety of nicotinic and muscarinic agonists in high concentrations such as 
propionylcholine, carbamylcholine, bethanechol, butyrylcholine, nicotine and 
methacholine. There were many reports showed the evidence for the existence of
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NANC nerve innervation. They were the retractor penis muscle of bull, dog and 
horse ( Klinge 1970a; Klinge & Sjostrand 1974; Ambache & Killick 1978 ), the 
anococcygeus muscle of rat, mouse, rabbit and cat ( Gillespie 1972; Gillespie & 
McGrath 1973; 1974; Creed et al. 1977 ), the rabbit rectococcygeus ( King et al. 
1977; King & Muir 1977; 1981 ), the guinea pig taenia coli ( Bennet et al. 1966 
), the lower oesophageal sphincter muscle of opposum ( Rattan et al. 1977 ), the 
oesophagus ( Lund & Christensen 1969 ), the guinea pig gall bladder ( Davison 
et al. 1978 ), the guinea pig trachea ( Coleman 1973; Coburn & Tomita 1973 ), 
the rabbit portal vein ( Hughes & Vane 1967 ), the penile arteiy of bull ( Dorr & 
Brody 1967; Klinge & Sjostrand 1974 ). Luduena and Grigas ( 1972 ) reported 
the dog retractor penis in vitro produced contraction in response to exogenous 
adenosine triphosphate ( ATP ) and prostaglandin F^,  and y-aminobutyric acid ( 
GAB A ) had was no effect. Prostaglandin Ex on other hand did relax the muscle 
and for this reason they suggested it might be the parasympathetic neuro­
transmitter in this tissue.
Klinge and Sjostrand ( 1974 ) reported a detailed study of the effects of drugs 
and nerve stimulation on isolated smooth muscle strips of the retractor penis and 
the penile artery of bull. They found the retractor penis exhibited rhythmic spon­
taneous activity and often sustained tonic contraction. Field stimulation pro­
duced a monophasic, biphasic or triphasic response ( inhibitory and /  or excita­
tory ) depending on the muscle tone. All of these effects were abolished by tetro- 
dotoxin or local anaesthetics and due therefore to nerve stimulation. The excita­
tory response to field stimulation was abolished by a-adrenergic neuron blocking 
agents or cx-adrenoceptor blocking drugs and enhanced by inhibition of neuronal 
noradrenaline uptake. The effects of adrenaline, noradrenaline and isoprenaline 
on the muscle were blocked by a- and p-adrenoceptor blocking agents. The
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inhibitory response to field stimulation was uncovered by adrenergic neurone 
blocking drugs. This inhibitory response was unaffected by antimuscarinic, gan­
glionic blocking, neuromuscular blocking drugs, antihistamines and serotonin 
antagonists. It was also not blocked by botulinum toxin or hemicholinium or 
potentiated by physostigmine. Acetylcholine at high concentrations produced 
contraction of the muscle, suppression of the excitatory response to field stimula­
tion and a brisk short lasting relaxation. The first two effects of acetylcholine 
were emulated by pilocarpine and abolished by antimuscarinic drugs. The relaxa­
tion was sometime proceeded by a rapid contraction, resembled the effect of 
transmural nerve stimulation, prevented by hexamethonium and emulated by 
nicotine. The relaxation induced by nicotine was abolished by ganglionic block­
ing agents or local anaesthetics. Histamine and 5-hydroxytryptamine also pro­
duced muscular contraction. The retractor penis was contracted by ATP. A 
number of other nucleotides and nucleosides had no effects or weak effects simi­
lar to those of ATP. GABA, glycine, glutamic acid, aspartic acid, alanine, valine, 
tyrosine, N-acetyltyrosine, tryptophan, cysteine, histidine, proline, hydroxypro- 
line, glutamine, asparagine, methionine, and lysine were all without effects. Pros­
taglandins E x and E 2 relaxed the retractor penis but prostaglandin contracted 
it. The inhibitory response of the retractor penis to field stimulation was not 
suppressed by prolonged exposure to inhibitors of prostaglandin synthesis, an 
observation excluding as the neurotransmitter as suggested by Luduena
and Grigas ( 1972 ). Substance P and minute concentration of bradykinin con­
tracted the retractor penis. Posterior pituitary hormone had no effect on it. They 
believed the motor nerves of retractor penis muscle were adrenergic. There was 
also an inhibitory nerve innervation in the muscle. The neurotransmitter released 
from the inhibitory nerves relaxed the muscle by direct action and was most 
probably a substance other than acetylcholine, isoprenaline, histamine, 5-HT,
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substance P, bradykinin, pituitary hormones, a prostaglandin, any of the nucleo­
tides, nucleosides or amino acid studied as described above. The relaxation 
induced by acetylcholine was probably due to nicotinic stimulation of the inhibi­
tory nerves.
The anatomical relationship between the non-adrenergic inhibitory neurones and 
the rest of the peripheral autonomic nerve system has been studied mainly in the 
gut. The cell bodies of non-adrenergic inhibitory neurones lie in Auerbach’s 
plexus ( Bumstock et al. 1966 ). In the gastrointestinal tract they are intrinsic 
neurones confined to the gut wall and with a mainly cholinergic input. In the 
stomach ( Martinson 1965; Campbell 1966; Bulbring & Gershon 1967 ) and the 
small intestine ( Bayliss & Starling 1899; Goldenberg & Bums 1968 ), the 
intramural inhibitory neurones are controlled by the pre-ganglionic vagal 
parasympathetic nerves. Klinge ( 1970b; 1970c ) reported a high content of nora­
drenaline, a large amount of acetylcholine and exhibition of acetylcholinesterase 
activity in the retractor penis of bull. Abundance of adrenergic fibres and 
acetylcholinesterase-positive fibres were exhibited by histochemical studies ( 
Klinge et al. 1970b; 1970c ).
In the taenia coli of guinea pig the inhibitory relaxation was poorly sustained if 
continuous stimulation was applied ( Bumstock et al. 1966 ). In the sphincteric 
muscle especially the internal anal sphincter the response to continued stimula­
tion was well maintained ( Rayner 1979 ). In the cat stomach relaxation medi­
ated by non-adrenergic inhibitory nerves was not readily fatigued ( Abrahamson 
1973 ).
Stimulation of the pelvic nerve neither brought about mechanical inhibition (
INTRODUCTION 10
Garry & Gillespie 1955 ) nor inhibitory junction potentials on the smooth muscle 
cells of the large intestine ( Furness 1969 ) although transmural stimulation 
caused inhibitory junction potentials in both circular and longitudinal layers ( 
Furness 1969 ). These inhibitory junction potentials were reduced by hex­
amethonium ( C6 ) suggesting an intrinsic cholinergic drive ( Fumess 1970 ). 
Electrical and mechanical responses in the guinea pig taenia coli and urinary 
bladder were reduced by lowering the external calcium ( Bumstock et al. 1978 ) 
implying the transmitter release was calcium dependent and the transmitter itself 
was probably held in membrane-bound storage vesicles, whose contents were 
released by exocytosis. In the gut-related anococcygeus muscle responses were 
potentiated by tetraethyl ammonium which was known to prolong the nerve 
action potentials so allowing more time for calcium entry ( Gillespie & Til- 
misany 1976 ). Another NANC nerve innervated tissues is anococcygeus, which 
extends to the retractor penis ( Gillespie & Martin 1980; Gillespie 1987 ). The 
anococcygeus was introduced as an ideal pharmacological preparation by Gil­
lespie ( Gillespie 1972 ) although there were some reports about the similar 
structures in the end of last century ( Langley & Anderson 1895 ). Gillespie ( 
1972 ) reported that the rat anococcygeus muscle had a dense adrenergic inner­
vation distributed throughout the whole muscle but with no obvious cholinergic 
innervation and no evidence of localised cholinesterase staining histochemically. 
This muscle contracted in responses to the noradrenaline, acetylcholine, fur- 
methide, 5-hytroxytryptamine, but not to histamine. Isoprenaline and ATP had no 
effect at low concentration but caused contraction at high concentration. Phento- 
lamine and atropine respectively abolished the effects of noradrenaline and ace­
tylcholine. When stimulated by field stimulation, this muscle produced powerful 
contraction, which was blocked by phentolamine, guanethidine but not atropine 
or hexamethonium. After the tone of the muscle was raised by guanethidine, 5-
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HT or furmethide, field stimulation of the muscle uncovered the inhibitory relax­
ation which was insensitive to hexamethonium but abolished by tetrodotoxin. 
This inhibitory response to nerve stimulation was neither abolished by atropine, 
phentolamine, phenoxybenzamine, propranolol, hexamethonium or lysergic acid 
diethylamide, nor mimicked by acetylcholine, isoprenaline or ATP although his­
tamine caused contraction and isoprenaline relaxation in rabbit and acetylcholine 
and isoprenaline relaxed the muscle in cat ( Gillespie & McGrath 1974 ). Gibson 
and Gillespie ( 1973 ) reported that the inhibitory relaxation induced by field 
stimulation of the muscle against tone raised by carbachol was not abolished by 
the partial denervation of adrenergic neurones by immunosympathectomy or vir­
tually complete destruction of the adrenergic neurones by 6-hydroxydopamine 
pre-treatment. Gillespie and McGrath ( 1973 ) also reported that the motor and 
the inhibitory nerve fibres innervated the anococcygeus had their origin in 
different regions of the spinal cord. The motor fibres were typically sympathetic 
with their origin in the upper lumbar region. The NANC inhibitory nerves ana­
tomically were typical parasympathetic nerves with origin on the sacral cord. 
This reinforced the earlier observation that destruction of the sympathetic nerves 
with 6-hydroxydopamine had no effect on the NANC fibres and established the 
latter as an anatomically district nerve fibre with an unknown neurotransmitter.
The mode of action of these NANC nerves has been studied. Creed et al. ( 1975 
) reported the contraction of rat anococcygeus due to the release of the noradre­
naline by field stimulation or guanethidine or addition of exogenous noradrena­
line into the bath was accompanied by depolarisation of the cellular membrane to 
above -20 mV. and a fall in cellular membrane resistance. These indicated the 
noradrenaline released acted by increasing the permeability of the membrane ion 
channel(s) probably to sodium. But the relaxation induced by inhibitory NANC
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nerve stimulation was not accompanied by any measurable change of the cellular 
membrane potential or resistance. The response to NANC nerve stimulation in 
the rabbit anococcygeus was accompanied by a large hyperpolarisation. In the 
latter muscle the mechanism of inhibition could be the closure of voltage sensi­
tive calcium channels in response to hyperpolarisation. In the rat muscle the 
absence of hyperpolarisation suggests relaxation must be the consequence of 
biochemical rather than electrical coupling.
INHIBITORY FACTOR ( IF )
The smooth muscle inhibitory factor ( IF ) extracted from the BRP was con­
sidered a promising candidate for the NANC inhibitory neurotransmitter first 
because it was extracted from tissue containing these nerves and secondly it 
possesses many properties required of such an inhibitory neurotransmitter.
IF was first extracted by Ambache et al. ( 1975 ) from the bovine retractor penis 
muscle by a dilute solution of hydrochloric acid. It was a thermolabile, water- 
soluble and ether-insoluble substance which powerfully inhibited the BRP and 
mimicked closely the inhibitory response to NANC relaxation of BRP and whose 
action was unaffected by drugs blocked conventional transmitters. They believed 
it could be the NANC inhibitory neurotransmitter in the BRP.
In this laboratory these results were verified and extended ( Gillespie & Martin 
1978; Gillespie & Martin 1980; Gillespie et al. 1981b ). The most important 
observation was that the IF as extracted from the BRP lacks biological activity.
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This appeared only after a brief exposure to acid at pH 3 or less. The material 
reported by Amboche had of course already been activated by the dilute acid 
used in the extraction. IF was also soluble in methanol, less so in ethanol and 
was insoluble in acetone. It existed in the two forms mentioned above, a rela­
tively stable but pharmacologically inert which was converted to an unstable but 
much more powerful inhibitory compound by a brief exposure to acid before 
neutralization and assay. Its molecular weight was estimated approximately at 
between 500 and 1000 Daltons by ultrafiltration of acid extracts of the BRP 
through a series of membranes with different molecular retention values. It is not 
ATP ( Bowman et al. 1979 ), a peptide ( Gillespie et al. 1981a ) or a fatty acid ( 
Gillespie & Martin 1980 ).
IF mimics the effects of NANC nerve stimulation in the BRP and the powerful 
NANC nerve innervated tissues, the penile artery, the guinea pig taenia coli and 
trachealis muscle, not only in the degree of the relaxation but also the time 
course of response ( Bowman & Gillespie 1983; Crossley & Gillespie 1983 ). 
The mode of action of IF and nerve stimulation was identical in BRP and penile 
artery but not in taenia coli since haemoglobin which blocked both the response 
to nerve stimulation and the IF in the BRP and rat anococcygeus did not block 
the response to nerve stimulation in the taenia coli ( Bowman & Gillespie 1983 
). Both IF and nerve stimulation produce membrane hyperpolarisation ( Byrne & 
Muir 1985 ). They caused relaxation by raising cyclic GMP level, an effect 
blocked by haemoglobin, N-methylhydroxylamine ( Bowman & Drummond 1984 
) and methylene blue ( Bowman et al. 1986 ) and potentiated by a selective inhi­
bitor of cyclic GMP phosphodiesterase M & B 22948 ( Bowman & Drummond 
1984 ). Ethanol also selectively inhibited the relaxation on the rat anococcygeus 
and BRP to NANC nerve stimulation and to IF without effect affecting the
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relaxant response to isoprenaline or even to other agents such as sodium 
nitroprosside which stimulated guanylate cyclase or to the phosphodiesterase 
inhibitor isobutylxanthine which prolonged the action of cyclic GMP. The 
mechanism of action of ethonal might be to reduce calcium binding to membrane 
or a reduced efficiency of receptor coupling ( Gillespie et al. 1982 ). The possi­
bility that the IF like other neurotransmitter was held in storage vesicles was 
examined ( Hunter 1982 ). BRP muscle was homogenised and separated into the 
conventional Pu P2» P3 and 53 fraction. The assumption was that if there are 
specific storage vesicle the IF would merely be in the P3 fraction. The results 
showed activity in all fraction but with a higher concentration in P3 suggesting 
storage in association with some form of particle. Martin et al. ( 1980 ) on the 
other hand reported there was evidence that IF extracted from BRP is nitrite, 
whose acid-activated derivative is stabilized nitric oxide. If this is so then the IF 
may be an artifact unrelated to the neurotransmitter though the stabilising factor 
might be related.
So far IF fulfils many of the requirements as the NANC inhibitory neuro- 
transmitter in BRP and rat anococcygeus but with some exception as IF needs 
for acid activation and could be extracted from various tissues which with or 
without NANC innervation ( Gillespie & Martin 1980 ). Also so far it failed to 
detect the release of neurotransmitter from the NANC nerve.
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ENDOTHELIUM-DERIVED RELAXING FACTOR ( EDRF )
Because the IF possesses several properties in common with the NANC nerves 
such as the ability to stimulate guanylate cyclase and its block by haemoglobin, 
it was regarded as a promising NANC inhibitory neurotransmitter. The experi­
mental difficulties in detecting its release by nerve stimulation and the failure to 
identify it chemically lead the research to investigate some substances which also 
have properties in common with the relaxation produced by NANC nerve stimu­
lation. These were EDRF and nitric oxide both like the NANC nerves and the IF 
are unstable, short acting relaxants acting through guanylate cyclase and blocked 
by haemoglobin.
EDRF was first recognised by Furchgott et al. ( 1980 ) in experiments with iso­
lated preparations of arteries ( rings, transverse strips or helical strips ). In such 
preparations the well known relaxant effect of acetylcholine was strictly depen­
dent on the presence of endothelial cells on the intimal surface of the prepara­
tions. This discovery resolved the paradox that acetylcholine though a powerful 
vasodilator in vivo often produces no relaxation or even contraction on isolated 
preparations of arteries in vitro. The explanation was that their endothelial cells 
were unintentionally rubbed off. This initial observation with acetylcholine has 
lead to the recognition that many other potent vasodilators also require 
endothelial cells to produce their effect.
EDRF is powerful relaxant on vascular smooth muscle, destroyed by haemoglo­
bin and borohydride acting through guanylate cyclase, has a short half-life and is 
chemically unstable ( De Mey & Vanhoutte 1983; Griffiths et al. 1984 ). Gil­
lespie and Shen ( 1988 ) reported the EDRF as well as IF powerfully relaxed
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vascular and some non-vascular smooth muscles.
EDRF can be released from vascular endothelial cell stimulated by acetylcholine, 
bradykinin, substance P and some related peptides, ATP and ADP, histamine, 
serotonin, thrombin, arachidonic acid and the calcium ionophore A23187 ( Fur- 
chgott & Zawadzki 1980; Furchgott 1981; Altura & Chand 1981; Chand & 
Altura 1981 ) although there are differences between species and different blood 
vessels. After removal of the endothelial cells, the vasoconstriction by noradrena­
line and serotonin is significantly more powerful ( Cocks & Angus 1983 ) indi­
cates the accompanying release of EDRF by these agonists. EDRF also inhibits 
platelet aggregation and adhesion to vascular endothelium ( Azuma et al. 1986; 
Radomski et al. 1987a; 1987b; 1987c ).
Drugs and experimental conditions which inhibit the endothelium-dependent 
relaxation are anoxia, ETYA ( 5,8,11,14-Eicosatetraynoic acid, an inhibitor of 
lipoxygenase ), quinacrine ( an inhibitor of arachidonic acid release ), p- 
bromophenacylbromide ( BPB, an irreversible inhibitor of phospholipase A2 ), 
NDGA ( nordihydroguiaretic acid, lipoxygenase inhibitor and antioxidant ), 
hydroquinone, methylene blue and haemoglobin ( De Mey & Vanhoutte 1983; 
Furchgott & Zawadzki 1980; Bowman & Gillespie 1981; Gruetter et al. 1981a; 
1981b; Furchgott et al. 1983; Singer & Peach 1983 ).
Drugs potentiating the effect of EDRF are M & B 22948, the selective inhibitors 
of cyclic GMP phosphodiesterase ( Martin et al. 1986 ).
The action of EDRF is mediated through stimulation of the soluble guanylate 
cyclase and the consequent elevation of cyclic GMP within the smooth muscle (
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Diamond & Chu 1983; Furchgott & Jothianandon 1983; Rapoport & Murad 
1983a; 1983b ).
Strong experimental evidence that EDRF is nitric oxide has been produced ( Pal­
mer et al. 1988a; 1988b ). Sufficient nitric oxide is released from endothelial 
cells to account for the biological activities of EDRF ( Palmer et al. 1987 ). 
Recently the same group have produced evidence that the Nitric oxide is syn­
thesized by vascular endothelial cells from the terminal guanidino nitrogen 
atom(s) of the amino acid L-arginine ( Palmer & Moncada 1989; Palmer et al. 
1988b; Schmidt et al. 1988b ).
The vascular relaxation by EDRF is inhibited by the inhibitors of L-arginine- 
utilizing enzyme L-monomethyl-N-arginine and L-canavanine ( Palmer et al. 
1988b; Schmidt et al. 1988a ). The release of nitric oxide from the cultured 
endothelial cells is also blocked by L-NMMA ( Palmer et al. 1988b ). This inhi­
bitory action of L-NMMA is appearently a competitive substrate inhibition since 
it can be reversed by L-arginine.
Nitric oxide is rapidly oxidized in presence of oxygen and water. This oxidation 
is greatly enhanced by the presence of superoxide anions present in all aqueous 
solution containing oxygen in solution and particularly in solution oxygenated 
with 95 % 0 2> It is by destroying these anions that superoxide dismutase protects 
EDRF from breakdown ( Gryglewski et al. 1986; Rubanyi 1986 ).
Although EDRF and the IF possess any properties in common, the IF does not 
act through the release of EDRF since removing the endothelium from an aortic 
strip which abolishes the relaxant effect of acetylcholine does not also abolishes
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the relaxant effect of the IF. There are also some properties of the IF which are 
appearently incompatible with it being EDRF ( NO ) such as a molecular weight 
of between 500 to 1000 ( Gillespie et al. 1981b ), difficulties in diffusing 
through cell membrane ( Gillespie & Shen 1988 ) and its relatively high concen­
tration in the washed high speed pellet from tissue homogeneous.
For the reasons given above EDRF, IF and nitric oxide are similar in many of 
their properties. The IF is perhaps the most promising NANC neurotransmitter 
because it mimics the action and effects of NANC nerve stimulation. If, bearing 
in mind that the possible relationship with nitric oxide, the release of the NANC 
inhibitory neurotransmitter could be detected, this would pave the way to a simi­
lar study of its properties and its likely identification. If detection is impossible 
then indirect studies of the relationship between the responses to nerve stimula­
tion, to EDRF and nitric oxide may through light on the nature of the NANC 
inhibitory neurotransmitter. These are the aims of this project.
- . / v  b t v i
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MATERIALS AND METHODS
In this project these isolated preparations, the bovine retractor penis ( BRP ) 
muscles, the rat anococcygeus muscles and rabbit aortic strips, were used. These 
preparations were used first in a series of experiments trying to identify by bioas­
say the release of neurotransmitter from field stimulated non-adrenergic non- 
cholinergic ( NANC ) nerves. A second group of experiments examined the 
effects of drugs on the response to NANC nerve stimulation and a comparison 
with the response to endothelium-derived relaxing factor ( EDRF ) and nitric 
oxide.
THE BOVINE RETRACTOR PENIS ( BRP ) MUSCLE
THE ANATOMY OF THE BOVINE RETRACTORS PENIS MUSCLE
The paired retractors penis muscle of bulls have their origin from the ventral sur­
face of the first and second coccygeal vertebrae. From their origin behind the 
colon the muscles run ventrally to pass the anal canal, one on either side of the 
colon, and proceed along the ventral surface of the bulbocavemousus muscle to 
the distal part of the penis where a broad insertion takes place. The paired mus­
cles maintain the characteristic sigmoid flexure of the relaxed penis ( Fig. 1 ). 
The bovine retractors penis muscles were obtained from Glasgow Abattoir. The 
BRP muscles were from bullocks of different breeds, weighing 200 to 1000 kg. 
The whole penis was removed complete with the paired retractors penis muscle
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as far as the ischiocavemosus muscle and the bulbocavernosus muscle. To ensure 
that only one muscle from each animal was used, the BRP was dissected in the 
abattoir and only one of the each paired retractors penis muscle was used and 
transferred in a bottle containing fresh made-up Krebs’ solution to the laboratory 
within 3 hours of slaughter. In the laboratory the muscles were cleared of con­
nective tissues and stored in Krebs’ solution or Tyrodes solution at about + 4° C 
in the refrigerator until required. Muscles were either used immediately or after 
storage for periods up to 2 days after slaughter. There was no any indication of 
disadvantage of a few hours’ delay in obtaining the BRP muscles from the abat­
toir after slaughter or their storage for 3 days in the Krebs’ or Tyrodes solution. 
In some experiments in order to exhaust the endogenous arginine in the BRP 
muscles, the muscles were purposely stored for periods up to 10 days. In these 
cold stored experiments four BRP muscle strips from four different bullocks 
were used on each successive day of the 10 day period.
THE BOVINE RETRACTOR PENIS MUSCLE PREPARATION
The BRP muscles were placed on a glass petri dish ( partly filled with sylgard ) 
containing Krebs’ solution and the muscles were pinned out. The connective 
sheath covering the muscles was removed to expose the muscle fibre bundles. 
Parallel bundles of muscle fibres were selected and longitudinal strips, 10 to 20 
mm. in length and about 1.5 to 2 mm. in width, were cut. In experiments to 
release the NANC inhibitory neurotransmitter and to detect this by bioassay 
much longer preparations 20 to 40 mm. in length and 4 to 6 mm. in width were 
sometimes used to increase the amount of the neurotransmitter released. In a 
series of experiments to test whether L-arginine was a physiological precursor of 
the NANC inhibitory neurotransmitter it was necessary to exhaust the
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endogenous arginine in the preparations. To do this preparations were stored in 
the cold in sterile Tyrodes solution for up to ten days with the sterile Tyrodes 
solution changed daily. Because a four channel pen recorder was used, it was 
convenient to have four preparations for each day’s experiment. To provide this 
ten preparations were cut from each of four fresh muscles and one preparation 
from each put into ten sterile tissue cultured bottles ( Fig. 2 ) containing 20 ml. 
of newly made up Tyrodes solution which had been sterilised by filtration 
through an ultrafilter ( Sartorius Minisart sterile 0.45 pm. max. 7 bar ). The 
BRP muscle strips were washed with sterile Tyrodes solution before they were 
put into the sterile culture bottles. Each day the Tyrodes was removed and 
replaced with fresh solution. All of these procedures, dissection, preparation of 
bottles and filling and refilling bottles, was carried out in a sterile hood. Between 
manipulations the bottles were stored in a refrigerator at 4° C. Tyrodes solution 
was preferred to Krebs’ because of its phosphate buffer which maintained a con­
stant pH. Krebs’ solution, if not gassed with 5 % C02, quickly becomes alkaline 
and the calcium phosphate precipitates out. No antibiotics were used partly 
because streptomycin at least is known to be able in skeletal muscle to interfere 
with neurotransmission.
On each experimental day one bottle containing the four preparations each from 
a different animal was placed in a hot water reservoir and slowly heated to 37° C 
and then kept at this temperature for 30 to 45 minutes. This allows the Na + /  
K  + ATP’ase pump to be restored and restore the normal intracellular ionic bal­
ance by pumping out Na + in exchange for K  + . After this equilibration period 
the preparations were removed and each end tied with 5:0 weight braided silk. 
One end was kept short for tying the preparation to a hook in the organ bath, the 
other was left long for connection to a Grass FT 03 tension transducer. Each
rt
0
X
ft
cr 0 *nC C+ H* 
t—■ i-j onh-J H- •o "a
0 to
s a
CD4 c 0 *0
<~3 *< 0 
4  c+ O 0a  40 H- 
0 I—1 
0
0o
H-1 rt 
G H- 
c+ 0  H- 0 
O G 3 0
Obd a 
O H-’ 
4  ct G
4> 0 
C CL 
4  
rt
nr 
0 4
rt ^o 0
m- ao  H- 
p
CL (JU 
P 4  
P 
3
< 
0 m m
CL 0  
0 t— 
rt- w
p
H-
0 o 
o
0  P 
H- 
c+ 3  
3- H' 
0  3
(m
oP  ^  H)
o  o
G rt 
4  nr 
in 0
rt- CL 
4  H- p  
H* t l )  4
^  H )  hj 
0  0 P 
4  3
0  ou
P 3  0
3  rt- 3  
CL 0
CD 3  
PO rt 
0  bdid
G 3  O 
P G 4  
h -J  0  
t—' O rt*<* i-* nr 
0 0 
0
CD n> po
4  43
ft o
4  3 3  h- c  cr *-f> w 
c o o
(+ C H  
0  4  0
a
a
H-
in
a
p
<
0
w
w
0
co
rr
4
H-
T3
0
COCO
CPCP
CDCD
CDCO
COCD
O
fO
CO
< Z >
o
B
R
P
MATERIALS AND METHODS 22
preparation was suspended in a 10 ml. organ bath containing Krebs’ physiologi­
cal saline at 36° C and aerated with 5 % C02 in 0 2. In some experiments studying 
the release of the NANC inhibitory neurotransmitter smaller 1 ml. baths were 
used. When the responses to the stimulation of intramural nerve fibres were stu­
died, one end of the strip was tied to a silver /  silver chloride hook electrode and 
the muscle strips passed through the silver /  silver chloride ring electrode embed­
ded in Araldite ( Bum and Rand 1960 ) with the long thread tied to a Grass 
force displacement isometric transducer. ( Figure 3 ). The ring electrodes con­
sisted of a coil of 0.5 mm. diameter silver wire, 4 mm. in length and of inside 
diameter 3 mm. embedded in Araldite epoxy resin, with a hook of silver wire 4 
mm. directly below the coil forming another electrode. During the experiments 
in which the responses to exogenous drugs only were studied, the BRP prepara­
tions were mounted on glass hooks.
In all experiments the BRP muscle strips were set up with no applied tension 
and allowed to equilibrate for 10 to 15 minutes and then given 1 gm. resting ten­
sion by repeated stretch of the strips controlling the amount of stretch by the ten­
sion displayed on the recorder. The tone of the BRP muscle strips were raised by 
addition of guanethidine ( 10-5M.) which has the additional advantage of blocking 
the motor adrenergic nerves.
ARRANGEMENTS OF THE PREPARATION IN THE DETECTION OF 
NANC NEUROTRANSMITTER
In the detection of the NANC neurotransmitter in the BRP muscles some other 
arrangements of the preparations were used purposely in an attempt to increase 
the quantity of the neurotransmitter released, reduce the dilution or to reduce the
Recorder
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Krebs 3?oC
E l e c trodes
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muscle strip
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Fig. 3 A diagram of the arra n g e m e n t  for field 
stimulation of the BRP or rat a n o c o ccygeus muscle 
strip in the isolated organ bath.
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delay between release and detection.
First, a donor BRP muscle strip was mounted inside the ring electrodes in a 
organ bath ( 1 ml. or 10 ml. ) described as above and stimulated by field stimu­
lation ( Fig. 4 ). A test BRP muscle strip was mounted above the donor BRP 
muscle strip and the ring electrodes 1 to 10 mm. or just outside the ring elec­
trodes but close to the donor BRP muscle strip at the same level. Sometimes a 
second test strip, the rabbit thoracic or abdominal aortic transverse strip, was also 
used and similarly placed just above and inside the ring electrode. These prepara­
tions were 2 mm. wide rings which were cut through to produce open strips 
about 10 mm. long.
Secondly, a cascade was used. The arrangement is in Figure 5. A donor BRP 
muscle strip was tied on the hook electrode with another end passing through the 
ring electrode and tied with a long braided silk thread ( EP 1 ) to the force trans­
ducer. A test BRP or rat anococcygeus muscle strip was tied below the donor 
strip and attached by a thread to another force transducer. All of these prepara­
tions were mounted inside a jacketed organ bath to maintain a warm and water- 
saturated environment. The jacket was circulated with water at 40° C. The Krebs’ 
solution, previously heated to 37°C and saturated with 5% C02 in 95% 0 2, flowed 
along a glass tube just above the donor strip and dropped on and superfused the 
donor strip. Then the superfusate was collected by a small glass tube just below 
the donor strip and superfused the test strip below. The constant flow of Krebs’ 
solution was maintained by a Watson-Marlow constant flow pump. Flow speeds 
of 1, 2, 4, 6, 8 and 10 ml. per minute were studied.
Finally, a closed cascade ( Fig. 6 ) was used. In the lower chamber the donor
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Fig. 4 A diagram of arrangement for the bioassay to 
detect NANC n e u rotransmitter released from the donor 
BRP muscle strip and detected by the close test 
rabbit aortic strip and another test BRP or rat 
anococcygeus muscles strip. For further details see 
the t e x t .
Krebs 37°C 9 5 % 0 2 5 % C 0 2
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BRP or rat a n o c o c c y g e u s
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Fig. 5. A diagrammatic representation of the open 
cascade system used to release NANC neurotr a n s m i t t e r  
from a donor BRP muscle strip and to detect the 
neurotransmitter by a test BRP or rat anococcygeus 
muscle strip immediately below the donor strip.
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muscle strip was tied to small Ag /  AgCl hook electrode while the second elec­
trode was a thin plate of Ag / AgCl 25 mm. long extending over the three walls 
of the chamber. The other end of the donor muscle strip was tied to the force 
transducer. The test BRP muscle strip was mounted in a second chamber 
immediately above the ring electrode. The volume of these chambers was 
approximately 1 ml. Sometimes another test rabbit thoracic or abdominal aortic 
strip was mounted very close to the donor BRP muscle strip inside the ring elec­
trode at the same level or just above the donor BRP strip and the ring electrode ( 
Figure 6 ). The speed of the superfusion flow was studied at different levels of 
0.5, 1, 2, 4, 6, 8, 10, 12 and 15 ml. per minute respectively, and some experi­
ments were done with stop-flow. The constant flow was carried out and main­
tained by a Watson-Marlow pump. The motor adrenergic nerves were blocked 
and the tone of the BRP and rat anococcygeus muscle strips was raised by 
guanethidine ( 10-5M. ). Where the rabbit aortic strip was used as a second test 
tissue, the tone of the donor BRP strip, the test BRP or rat anococcygeus strip 
and the test rabbit aortic strip was raised by NA ( l(T*M. ), with EDTA ( 10~5M. 
) and ascorbic acid ( lO^M. ) to protect NA from being destroyed by oxidation. 
Occasionally Phentolamine ( 10-5M. ) was used to block the adrenergic excitation 
and tone raised with 5-HT ( 10-5M. ). The drugs were added into the Krebs’ 
solution reservoir when superfusion was used. In other experiments to prove the 
system capable of detecting the release of a known neurotransmitter noradrena­
line both the donor and the test strips were mounted under 1 g resting tension 
but without adding agonist drugs to raise tone or drugs to block the adrenergic 
nerves. In these circumstances field stimulation of the donor tissue caused the 
release of noradrenaline and contraction. The released noradrenaline could then 
be detected as contraction in the test tissue.
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THE RAT ANOCOCCYGEUS MUSCLE
THE ANATOMY OF THE RAT ANOCOCCYGEUS MUSCLE
The paired rat anococcygeus muscles arise from tendinous origins on the first 
two coccygeal vertebrae in the midline of the pelvic cavity. At their origin they 
lie close together behind the colon. They then pass on either side of the colon, 
merge onto the ventral surface of the colon and unite together as a longitudinal 
ventral bar which passes into the skin of the perineum. In some rats some fibres 
of the anococcygeus muscles form a short transverse bar merging on the ventral 
surface of the colon. The paired muscles may consist of thousands of individual 
smooth muscle cells merged in parallel bundles. Each smooth muscle cell has an 
irregular outline because of numerous caveolae and projections ( Gillespie & 
Lullman-Rauch 1974 ). The extrinsic nerves pass in a branch of the perineal 
nerve on either side to enter the deep surface of each muscle just short of the 
formation of the ventral bar ( Figure 7 ).
THE RAT ANOCOCCYGEUS MUSCLE PREPARATION
The rat anococcygeus muscles were dissected and removed as described by Gil­
lespie ( 1972 ). Mainly, 250 to 450 gm. male Wistar rats were killed by inhaling 
carbon dioxide or by stunning and exsanguination. The abdomen was opened and 
the vasa deferentia, seminal vesicles, testes, cremaster, bladder and urethra were 
also removed. After the removal of the fatty tissue adhering to the muscles of the 
hindlimbs, the skin of the perineum was reflected back. With care not to damage 
the underlying colon, the bulbo-cavemosus and ischiocavemosus muscles were 
cut through the symphysis pubis split and the two cut end of the pelvic arch
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Fig. 7. The schematic d r a wing of the male rat 
anococcygeus muscles in situ.
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forced apart. By this method the pelvic cavity was very clearly exposed. The 
perineum was stretched apart and pinned on a wooden block on which the rat 
was lying. Then the ventral anococcygeus was very clearly visible, locating close 
to the skin of the perineum. The fat and the attached tissues were carefully 
removed. After the colon was cut through at the level of the pelvic brim and the 
pelvic portion was pulled forward ventrally, the pair of anococcygeus muscles 
came into view. The anococcygeus muscles were cleared, their tendinous ends 
tied and the muscles removed between the tendinous coccygeal connections and 
the perineal end of the ventral bar, a length of about 30 to 40 mm. The muscles 
were transferred to a petri dish containing fresh aerated Krebs’ solution and 
pinned out onto a translucent gel covering the bottom of the dish. With very 
sharp scissor the remaining connective tissues were removed carefully and the 
transverse bar was cut, the paired anococcygeus muscles were divided into two 
preparations about 3 to 4 cm length and 2 to 4 mm. width by cutting longitudi­
nally throughout the midline of the longitudinal bar. Both ends were tied with 
braided silk ( EP1 ), one on the electrode hook in the bath and another with a 
long thread through the ring electrode on the force transducer. The dissection 
was completed within 15 to 20 minutes and the anococcygeus muscles were 
always kept moist by application of the fresh Krebs’ solution. The preparations 
were mounted under 1 gram resting tension by stretch in 10 ml. or 1 ml. baths 
and bathed in the Krebs’ solution and allowed to equilibrate for 60 to 90 minutes 
before experiments were begun. The tone of the anococcygeus preparations was 
usually raised by the addition of guanethidine ( 10_5M. ).
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THE RABBIT AORTIC STRIP PREPARATION
Rabbit thoracic or abdominal aortic strips were used. New Zealand white rab­
bits, 2 to 3 kg. of either sex, were killed by inhaling carbon dioxide. The chest 
and abdomen was opened. The thoracic or abdominal aorta was carefully 
dissected and then removed into Krebs’ solution in a dish. The aorta was gently 
cut into rings about 2 to 3 mm. width. Then the rings were cut longitudinally 
into transverse strips. Great care was taken during the whole procedure to avoid 
unnecessary stretch or contact of instruments with the luminal surfaces of the 
strips to ensure integrity of the vascular endothelium. In some experiments the 
endothelium was purposely disrupted by gently rubbing a small moist cotton ball 
on the luminal surfaces of the aortic strips. In all strips the integrity of the 
endothelium was judged by the presence ( with intact endothelium ) or absence ( 
disrupted endothelium ) of endothelium dependent relaxation induced by acetyl­
choline. The tone of the strips was raised by 5-HT ( 10-5M. ) or NA ( lO^M. ) 
in the experiments of the detection of the NANC neurotransmitter or by 
phenylephrine ( 7.5xlO-7M. ) to obtain submaximal contraction of the strips in the 
experiments of the effects of L-NMMA and exogenous L-arginine on the rabbit 
aortic strips. The strips were allowed to equilibrate 60 to 90 minutes before 
experiments were begun. After each wash to remove drugs and before the next 
step of experiments the strips were also allowed to equilibrate until the tone 
recovered.
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TEMPERATURE
The Krebs’ solution both in the isolated organ baths and in the tubes linked with 
the baths was maintained at 37°C by the circulatory jacket water pumped and 
heated by a constant heater pump ( Techne Tempette Junior TE-8J ).
TONE OF THE PREPARATION
Generally, guanethidine 10-5M. is chosen to be used in the study of NANC inhi­
bitory neurotransmission in the BRP and rat anococcygeus as it is the most 
effective drug in uncovering NANC inhibition because guanethidine meets the 
two requirements for optimum NANC inhibitory responses, first the tone of the 
preparation must be raised and secondly the motor adrenergic response blocked.
When rabbit aortic preparation was used as a second testing tissue in the bioas­
say detection of NANC inhibitory neurotransmitter, the tone of the tissues ( 
BRP, rat anococcygeus and rabbit aortic preparations ) was raised by 5-HT 
10~5M. with phentolamine 10"5M. to block the excitatory response, as guanethi­
dine is not suitable to raise the tone of rabbit aortic preparation.
In study of effects of drugs on endothelium-dependent relaxation in rabbit aortic 
preparation, phenylephrine 7.5xiO_6M. was used to raise tone of the preparations 
as it maintained a suitable and much stable tone.
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FIELD STIMULATION
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Field stimulation of the intermural nerves ( Bum & Rand 1960 ) was applied 
through the silver /  silver chloride electrodes with rectangular shocks of 0.5 mil­
lisecond pulse width and supramaximal voltage. The pulses were delivered from 
Grass S88 stimulator. In the experiments of the pharmacological analysis of the 
effects of drugs on the responses to field stimulation, the preparations of the BRP 
muscles were generally stimulated for 20 pulses at 3 minutes’ intervals. The fre­
quencies of the stimulations used were usually at 0.1, 0.2, 0.5, 1, 2, 5 and 10 Hz. 
But with exceptions sometimes, for example continuous higher frequencies were 
used in an attempt to exhaust the endogenous arginine in the BRP muscles, much 
exceptions are indicated in the text and the figures.
RECORDING OF MECHANICAL RESPONSES OF THE PREPARA­
TION
Mechanical responses of the smooth muscle strips were recorded isometrically by 
means of Grass force-displacement transducers FT 03 C coupled to and 
displayed on a four channel Grass Model 7 polygraph ink-writing recorder.
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SOLUTIONS 
KREBS’ SOLUTION
The composition of the Krebs’ solution used was based on that described by 
Krebs and Henseleit ( 1932 ). Namely,
N aC l 118.5 mM. K C l 4.75 mM. C aC l2 2.25 mM.
N a H C 0 3 25 mM. K H 2P 0 4 1.2 mM. M g S 0 4 1.2 mM.
Glucose 11.1 mM.
Each component was prepared as a concentrated stock solutions. When the stock 
solution of NaHC03 was made up, it was usually bubbled with C02 for 1 hours. 
The Krebs’ solution was made up from the stock solutions apart from glucose, 
which was added into the mixtures as the solid daily. The final Krebs’ solution 
was bubbled with 5 % C02 in 0 2 for 30 minutes before use. In the experiments 
to detect NANC neurotransmitter or using NA to raise the tone of the smooth 
muscle strips, Krebs’ solution was made up with deionised distilled water and 
ascorbic acid ( 10^M. ) and EDTA ( 10_5M. ) were added.
TYRODES SOLUTION
In those cold stored experiments where preparations were kept in the cold for up 
to ten days, Krebs’ solution was unsuitable since in the absence of the 5 % CO 2 
it gradually becomes alkaline and the calciumion precipitated. For these experi­
ments Tyrodes solution was used. The composition of the Tyrodes solution ( pH
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7.4 ) in grams per 1000 ml. was
N aCl 8.0 KC l 0.2 C aC l2 0.2 M gC l2 0.1
N a H C 0 3 1.0 NaH 2P O 4 0.05 Glucose 1.0
The solution was made up daily with distilled deionised water.
DRUGS AND COMPOUNDS USED
Drugs and compounds used were added into the isolated organ baths in the smal­
lest possible volumes ( 50 to 300 pM. ) usually by a microsyringe. The drug 
solutions were generally made up as concentrated stock solutions ( 10_2M. ) in 
deionised distilled water. Serial dilutions to the enquired concentrations were 
made up from the stocks in 9 % saline or distilled deionised water. All the con­
centrations in the text and the figures were the final concentrations in the baths.
Acetylcholine Chloride 
L-Arginine Hydrochloride 
L-Ascorbic Acid 
L-Canavanine Sulphate 
EDTA
Guanethidine Sulphate 
L-monomethyl-N-arginine 
D-monomethyl-N-arginine 
Noradrenaline Bitartrate
Koch-Light
Sigma
Koch-Light
Sigma
Koch-Light
CIBA
Welcome Research Laboratories 
Welcome Research Laboratories 
Koch-Light
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Phentolamine Mesylate CEBA
L-Phenylephrine Hydrochloride Koch-Light
Serotonin Creatinine Sulphate Koch-Light
Superoxide Dismutase Sigma
Acetylcholine, L-arginine, serotonin, L-NMMA, D-NMMA and L-canavanine 
were all made up as 10-2M. ( occasionally 10-1M. ) stock solutions. Each stock 
solution was divided into 1 ml. aliquots put into small plastic containers and 
stored in the deep freeze for future use.
Noradrenaline was made up as 10~2M. stock solution in glass distilled deionised 
water previously titrated to pH 3 with IN. HC1 and dilutions were made in the 
water from the stock.
SOLUTION OF NITRIC OXIDE
The solution of nitric oxide was prepared immediately before use. Gaseous nitric 
oxide, 99% pure, was obtained from BDH. One end of a soft rubber tube was 
connected with the cylinder containing nitric oxide with the another end under 
water. Enough gas was passed trough to clear the air from the tubing. A fine 
hypodermic needle attached to an air-tight syringe was then used to pierce the 
tubing wall near the cylinder. 0.65 ml. of nitric oxide gas was drawn into the 
syringe and then injected at atmospheric pressure into 65 ml. of helium deoxy­
genated normal saline which filled completely a brown bottle sealed with a 
rubber seal. This produced a stock solution with a nominal concentration of 
4.4xi0'4M. in the stock solution. The solution of nitric oxide was freshly made 
up daily and protected from light.
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Normally the solutions of drugs and compounds used during the experiments 
were kept in ice. Unless otherwise stated all effects of the drugs and the com­
pounds were verified on not less than eight preparations.
ABBREVIATIONS USED IN THE TEXT AND THE FIGURES
Ach Acetylcholine
ARG L-Arginine
BRP Bovine Retractors Penis
t-BRP Test Bovine Retractor Penis
d-BRP Donor Bovine Retractor Penis
CAN L-Canavanine
EDRF Endothelium-derived relaxing Factor
EDTA Ethylenediaminetetraacetic Acid
Hb Haemoglobin
5-HT Serotonin
NA Noradrenaline
NANC Non-adrenergic Non-cholinergic
L-NMMA L-monomethyl-N-arginine
D-NMMA D-monomethyl-N-arginine
P Probability
RAS Rabbit Aortic Strip
SOD Superoxide Dismutase
TTX Tetrodotoxin
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STATISTICS
Sets of observations were expressed as the mean +/- one standard error of the 
mean ( s.e.m. ) in appropriate tables and charts. The significance of the 
difference between sets of means was analysed and estimated normally by using 
the student’s t-test. Where the variance was unequal and the student’s t-test was 
invalid, the U-test ( Mann-Whitney te s t) was used instead. The probability more 
than 0.05 is considered no significant difference, less than or equal to 0.05 is 
significant, and less than or equal to 0.01 is very significant between sets of 
means.
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RESULTS
THE BIO ASSAY DETECTION OF THE NANC NEUROTRANSMITTER
While non-adrenergic non-cholinergic ( NANC ) nerves are known to innervate 
the bovine retractor penis muscle ( Klinge et al. 1970; Klinge & Sjostrand 1974; 
Ambache & Killick 1978 ) and the rat anococcygeus muscle ( Gillespie 1972; 
Gillespie & McGrath 1973; Gillespie & McGrath 1974; Creed et al. 1977 ), the 
neurotransmitter is still unknown. Many substances especially some known neu­
rotransmitters were rejected as the non-adrenergic non-cholinergic neuro­
transmitter ( Klinge & Sjostrand 1974 ). Now the most likely candidates are 
focused on the endothelium-derived relaxing factor ( EDRF ), nitric oxide ( NO 
), and the inhibitory factor ( IF ) extracted from the BRP muscles because of 
their many properties in common with each other. Among these three candidates 
the IF is very promising. Many attempts have been made to analyse and classify 
the non-adrenergic non-cholinergic neurotransmitter on the basis of drug interac­
tion with the NANC response. Other attempts have been made to isolate and 
purify and chemically identify the IF but with only partial success. If the non- 
adrenergic non-cholinergic neurotransmitter released from the BRP muscles, on 
the other hand, could be detected by bioassay, it would obviously pave the way 
to investigate the properties of the non-adrenergic non-cholinergic neuro­
transmitter and the effects of drugs on it and its nerves and receptors, to extract 
and purify the neurotransmitter, and finally to identify the neurotransmitter. Such 
attempts to detect the neurotransmitter in a Loewi-type experiment have been
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made in this laboratory before without success. It was hoped that new informa­
tion from work on EDRF if appeared to BRP might change this.
THE RELEASE AND DETECTION OF THE NANC INHIBITORY NEURO- 
TRANSMITTER IN THE BRP MUSCLE
BRP muscle strips were mounted in the baths as illustrated in Fig. 4 and tone 
raised by guanethidine ( 10-5M ). The NANC inhibitory relaxation of the donor 
BRP muscle strips was induced by field stimulation and detected by relaxation of 
the raised tone. Many methods were used to try to increase the release of the 
NANC inhibitory neurotransmitter and to improve its chances of diffusing to the 
bath fluid to be detected by the test BRP muscles. For example thinner donor 
BRP muscle strips ( 15 to 20 mm. length, 2 to 4 mm. width ) to improve 
diffusion or bigger donor BRP muscle strips ( 20 to 30 mm. length, 4 to 6 mm. 
width ) to increase the total released. The possibility of increasing the sensitivity 
of the detection system was explored by using different test tissues ( BRP mus­
cles, rat anococcygeus muscles or rabbit aortic strips ). The field stimulation 
parameters were carried always through with supramaximal voltage. The 
numbers of pulses ranged from 10, 20, 50 up to 100 at frequencies 0.1, 0.2, 0.5, 
1, 2, 5 and 10 Hz, different durations of stimulation from 10, 20 seconds, or 60 
seconds at 0.1, 0.2, 0.5, 1, 2, 4, 8, 16, 32, 64 and 128 Hz, or continuous field 
stimulation of supramaximal voltage at frequencies 5, 10, 20 or 40 Hz for 60 or 
120 seconds respectively. None of these gave any indication of a response of the 
test tissue strips related to NANC inhibitory relaxation of the donor BRP muscle 
strips ( Fig. 8 and Fig. 9 )
0 . 1 0.2 0.5 2 10 Hz
d-BRP
t-BRP
3 H .
Fig. 8 Compares the response of the donor BRP 
preparation ( d-BRP ) to stimulation of its NANC 
nerves at the frequencies shown above each response 
with the failure of the test prep a r a t i o n  ( t-BRP ) to 
show any response. Stimulation was by 0.5 ms. pulses 
at supramaximal voltage for 10 seconds. Tone was
raised in both preparations by g uanethidine 10 ~ 5 M i n 
the Krebs' solution. Bioassay in a bath as in figure 
4 .
d-BRP
3 g
5Hz
10s
1 0 H z
120s
1 0 H z
240s
t
M .
t-BRP
0 . 3g
Fig. 9 Compares the response of the donor BRP 
preparation ( d-BRP ) to stimulation of its HANG 
nerves at the frequencies and for d u r ation shown 
above each response with the failure of the test 
preparation ( t-BRP ) to show any response. 
Stimulation was by 0.5 ms. pulses at supramaximal 
voltage. Tone was raised in these p r e p a rations by 
guanethidine 10-5M in the Krebs' reservoir. Bioassay 
in a bath as figure 4.
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RELEASE AND DETECTION OF NANC NEUROTRANSMITTER IN A 
CASCADE SYSTEM
It was possible in the experiments described in the previous section that the dilu­
tion of released neurotransmitter by the bath fluid was too great for detection. 
Therefore a superfusion system greatly reducing the volume was used. In such a 
system it was possible the NANC inhibitory neurotransmitter could be detected. 
The arrangement for these experiments is illustrated in Figure 5. Before the 
experiments were begun, the test and the donor tissues were superfused to equili­
brate for 60 to 90 minutes. The Krebs’ solution flow rate from the Watson- 
Marlow constant flow pump was coliberated in advance and temperature adjusted 
to 37° C by a thermistor controlling the bath temperature. The test tissues were 
very close to the donor BRP muscle strip in order to shorten the time for the 
superfusate dropping on the test tissue. Different test tissues ( BRP muscle, rat 
anococcygeus muscle or rabbit aorta ), differently sized donor BRP muscle strips 
( 20 to 40 mm. length, 5 to 10 mm. width for the bigger strips or 15 to 20 mm. 
length, 2 to 4 mm. width for the thinner strips ), different parameters of the field 
stimulation ( higher or lower frequencies, shorter, longer or continuous stimula­
tion ), and different output of the Krebs’ superfusate flow ( 0.5, 1, 2, 4, 6, 8, 10, 
12 or 15 ml. per minute ) were studied. No inhibitory response of the test tissues 
was even observed in spite of powerful and maintained NANC inhibitory relaxa­
tion of the donor tissue in response to field stimulation. Drugs to raise tone in 
the donor and test tissues were added to the Krebs’ solution in the reservoir. 
Where the BRP was used as the only test tissue, guanethidine ( 10~5M ) was 
used. With the rabbit aortic strip as a second test tissue phentolamine ( 10_5M ) 
to block a adrenergic excitation plus serotonin ( 10"5M ) was used.
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THE RELEASE AND DETECTION OF THE NANC NEUROTRANSMITTER 
IN A CHAMBER SYSTEM
The closed cascade illustrated in Figure 6 had been used in this laboratory very 
successfully to demonstrate and study the release of EDRF from rabbit aortic 
endothelium. Since there may be a relationship between the NANC neuro­
transmitter and EDRF, it was felt to be worthwhile testing whether similar condi­
tions would be successful with the NANC neurotransmitter. The chamber con­
taining 1 ml. Krebs’ solution and the arrangements for the test and the donor tis­
sues are illustrated in Fig. 6. Where the test preparations were the BRP and rat 
anococcygeus muscle strips, these were always above the ring electrode and the 
donor BRP muscle strip to prevent escaping current stimulated their own NANC 
nerves. When the test preparation was rabbit aortic strip, this could be main­
tained very close to the donor BRP tissue because in the absence of NANC 
nerves the rabbit aortic strip had no inhibitory response to the field stimulation. 
The tone of the test and the donor strips was raised by guanethidine ( 10-5M ), or 
5-HT ( 10-5M ) with phentolamine ( 10-5M ), or noradrenaline ( KT^ M ) added 
into the Krebs’ solution reservoir. Again, many methods were used to try to 
detect the NANC inhibitory neurotransmitter i.e. differently sized donor BRP 
muscle strip ( 30 to 40 mm. length, 3 to 4 mm. width to release more NANC 
neurotransmitter, or 15 to 30 mm. length, 2 to 3 mm. width to increase diffusion 
), different flow rates of the Krebs’ superfusate solution ( 0, 0.5, 1, 2, 4, 6, 8, 10, 
12 or 15 ml. per minute ) and different parameters of the field stimulation ( 
numbers of pulses carrying from 10, 20, 50 or 100 respectively at frequencies 
0.1, 0.2, 0.5, 1, 2, 5 and 10 Hz, or a fixed time of the stimulation of 10 or 20 
seconds at frequencies 0.1, 0.2, 0.5, 1, 2, 5 and 10 Hz, or continuous field stimu­
lation for 60, 120 or 180 seconds at 2, 5 or 10 Hz, with supramaximal voltage 
and 0.5 milliseconds’ pulse duration ). All failed to successfully detect any
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NANC inhibitory neurotransmitter released from the donor BRP muscle by the 
test tissues ( Fig. 10 and Fig. 11 ).
As a control the same system and the conditions were used to demonstrate 
release of the endogenous neurotransmitter noradrenaline by field stimulation 
from the same donor BRP muscle and to compare this with known concentra­
tions of exogenous noradrenaline ( lO^M ) by the test tissues. Both BRP and 
rabbit aortic strips as the test tissues were successful in detecting noradrenaline 
released from the donor BRP muscle by field stimulation ( Fig. 12 and Fig. 13 ). 
The amount released was less than lO^M noradrenaline showing that the test sys­
tem was very sensitive at least to another known neurotransmitter noradrenaline.
In these experiments both endogenous and exogenous noradrenaline was 
prevented from being destroyed in the Krebs’ solution by use of distilled deion­
ised water to make up the Krebs and addition of EDTA ( lO^M ) and ascorbic 
acid ( l(T5M ) to chelate any remaining heavy metal ions such as iron that could 
chelate the oxidation of noradrenaline. It was possible the failure to detect the 
NANC inhibitory neurotransmitter was due to a similar destruction of the NANC 
neurotransmitter and only if this could be prevented would it be possible to 
detect it. It is difficult to decrease such problem since the chemical nature of the 
NANC neurotransmitter is unknown. However, there are reasons to think it 
related to EDRF and nitric oxide which are rapidly destroyed by superoxide 
anions. Superoxide dismutase which protects EDRF might therefore both poten­
tiate the response of the donor tissue and allow detection in the test tissues. This 
possibility was therefore investigated.
d-BRP
t-BRP
O.lg [
10Hz
60s
Flow speed
10 ml/M.
d-BRP
lg
t-BRP
O.lg
10Hz
120s
[
30Hz
180s
30Hz
180s
2 ml/M.
j
3M .
Fig. 11 Compares the response of donor BRP ( d-BRP ) 
preparation to stimulation for periods of time 
v a ryin g from 60 to 180 seconds and at fre quencies of 
5, 10 or 30 Hz with the failure of the test BRP
( t-BRP ) to response in any combination of 
conditions. Flow rates were either 10 ml. / m i n . 
( upper part of records ) or 2 ml. / min. ( lower 
part of records ). Tone was raised by guanethidine 
10~5M . in the Krebs' solution. Bioassay in a closed 
cascade as in figure 6.
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THE EFFECT OF SUPEROXIDE DISMUTASE ON THE NANC INHIBI­
TORY RESPONSE
EDRF is inactivated by superoxide anion in the effluent from superfused 
endothelial cells. Superoxide dismutase enhances the amount of EDRF released 
from the endothelial cells in the effluent ( Gryglewski et al. 1986; Rubanyi & 
Vanhoutte 1986 ) because Superoxide dismutase destroys the superoxide anion ( 
Apps & Hamden 1985 ). If the NANC neurotransmitter is nitric oxide, it was 
very likely that superoxide dismutase would prolong the half-life and potentiate 
the response.
THE EFFECT OF SUPEROXIDE DISMUTASE ON THE ISOLATED BRP 
MUSCLE IN A BATH
The BRP muscle strips were mounted in 10 ml. organ baths shown in Fig. 3. 
The tone of the strips was raised by guanethidine 10~5M. The NANC inhibitory 
relaxation of the BRP muscle strips was induced by field stimulation on the 
NANC nerves. The effect of different concentrations of superoxide dismutase on 
the BRP muscle was studied at different frequencies, numbers of pulses and 
durations of field stimulation at supramaximal voltage and 0.5 milliseconds of 
pulse duration. There were no effects of the superoxide dismutase on the NANC 
inhibitory relaxation at final concentrations of 10, 20, 40, 80, 100, 200, 300 and 
400 u./ ml. on responses to 10, 20, 50 or 100 pulses, or for 10 or 20 second of 
stimulation at 0.1, 0.2, 0.5, 1, 2, 5 and 10 Hz frequencies even higher frequen­
cies of 16, 32, 64 and 128 Hz. Also superoxide dismutase had no effect on the 
tone of the BRP muscles. These results suggested that superoxide dismutase had 
no protective effect on the NANC inhibitory neurotransmitter. Fig. 14 and Fig.
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15 are the typical examples of the effect of superoxide dismutase on the NANC 
inhibitory relaxation of BRP muscles.
THE EFFECT OF SUPEROXIDE DISMUTASE ON THE BIOASSAY OF THE 
TEST AND THE DONOR TISSUES IN A BATH
In spite of the failure of superoxide dismutase to potentiate the response to nerve 
stimulation, it might still protect that protein of the NANC neurotransmitter 
diffusing to the bath. It was possible that superoxide dismutase had no effect on 
the NANC inhibitory relaxation because the neuromuscular junctions of the 
NANC nerves are very tight so that the NANC inhibitory neurotransmitter avail­
able for superoxide dismutase to act was too short before the combined either 
with its specific receptor or diffused into the cell to act on guanylase cyclase. It 
was therefore considered worthwhile to see whether superoxide dismutase could 
protect the NANC inhibitory neurotransmitter released by a donor BRP muscle 
and allow it to be detected on the test tissues ( BRP muscle, rat anococcygeus 
muscle or rabbit aorta ).
In a 1 ml. isolated organ bath a donor BRP muscle strip and one or two test tis­
sue strips ( BRP muscle, rat anococcygeus muscle or rabbit aorta ) were mounted 
as shown in Fig. 4 and Fig. 6. The tone of the tissues was raised by guanethidine 
( 10_5M ), or if the rabbit aortic strip was used as a second test strip, 5-HT ( 
10~5M ) with phentolamine ( 10~5M ) was used. The donor BRP muscle strip was 
field stimulated and the NANC relaxation displayed. Final concentrations of 
superoxide dismutase from 10 u./ ml. up to 200 u./ ml. Krebs’ solution were 
used. The presence of the superoxide dismutase neither potentiated the NANC 
inhibitory relaxation in the donor BRP muscle strip, nor revealed any inhibitory
SOD 0 . 1 0 . 2 0 . 5  1 2 5 10 H:
4 # • t  ♦ • «
C o n tr ol
100 u./ ml
200  u
300 u .
«e«
3g
3m
Fig. 14 The effect of superoxide dis mutase ( SOD ) 
on the NANC inhibitory relaxation of BRP muscles to 
field stimulation ( supr amaxi mal voltage and 0.5 
mil lis econds for 10 seconds ). The records are from a 
single experiment in which increasing concentrations 
of 100, 200 and 300 u./ ml. of SOD were added to the 
bath ( Fig. 3 ) before repeating field stimulation. 
SOD had no effect on the NANC response. Tone was 
raised by guanethi din e 10-5M . in the bath as Fig. 3.
CDrt rt >-33 0 H- ro
rt) O 0 rr H* rt 3 H-
rt) 03 0 H- rr OH
CD rt *0 »-• 3 H- •
O rr o rt H- 3 cr
ft" CD 3 0 0 h-> H* r-*
03 o 0 P rt- cn
O c r  cd o O c+ o
3 p 0 i-t O H* 1-t
rt a 3 Ort* rr 0 0 a  3 r5rr rr 0 rr
CD P o pi s 03 X! rj tj
rj a  3 0 *0 0 0
CD 3 f—1ro
0 rt H- I—1 P ro
0 rr 3 H) 0 1—LX 0o 0 rj 0 o P o3 rt o o rt- rt
0 hj rr 3 a H*
CD 0 0 3 O O0 rj *0 3 H)10 c p Pi 3c ro rt t—1 00 ro H* 0 O 33 0 0 O 0 H) roQ 4 H- 3 0 0V} 3 41 rt OH'—- rt O0 0 h-1 rr X0 o 0 Pi 0 H-0 o on a►0 rt 0 Pi 0 0
O a  x H* 3 ro3 0 ►0 3 *0 ro a0 '■ 0 0 rj ro H-0 rj rt P 0COH- 3 3>-< O 3 OH P 30 a 0 3 X 3 rt'a 3 P H- 3 P
0 rt 3 3 0 0
0 o 0 P Q 0
rt o rt- i—11—10 rr 0 /^ S
CL c H-
>  a < COH) H- O 0 O
\ rt- 3 I—1rt a
0 0 rr rt3 rj i P H-COI—> H- OH*0O ct 3 0 oO rr a 3
2 0 3 rt
P O P O rtrr 0 o 0 3 rrP o a a 0
CL0 3 rt)
a rt rt H- *za 4 O o 0 >3 0 O 3 • 1—1S3o a I-* 0 cn a Q
CO
3
RESULTS 42
response in the test preparations as shown in Fig. 16. That superoxide dismutase 
did not uncover either a potentiation in the donor tissues or protection of the 
NANC neurotransmitter in the bath suggests that superoxide anion released from 
the tissues or existing in the oxygenated Krebs’ solution did not account for 
failure to detect the NANC inhibitory neurotransmitter.
ARTIFACTS IN THE DETECTION OF NEUROTRANSMITTER 
RELEASE
In using bioassay to detect release of NANC neurotransmitter it is necessary to 
use a high sensitivity of the transducer and polygraph. Such conditions make it 
easy for artifacts to suggest neurotransmitter is released and detected. In previous 
attempts to demonstrate neurotransmitter release, the escape of current to the test 
tissue, changes in pH and the release of chlorine by electrolysis at the electrodes 
applying the field stimulation to the donor tissue have all caused stimulation 
related inhibition of the test tissues but not related to NANC neurotransmitter 
released. In the present experiments the use of Ag / AgCl electrodes eliminated 
the problem of electrolysis but the escape of current from the donor tissue elec­
trodes to the test tissue still remained a problem. This is illustrated in Figure 17. 
Stimulation of the donor BRP muscle clearly produced a relaxation of the test 
tissue. One suspicious feature was the shape of the response which was similar 
to that in donor BRP tissue and coincided exactly with it. If it had been due to 
released NANC neurotransmitter, it would be expected to be smaller in magni­
tude but longer lasting because of the dilution and delay in the bath. An alterna­
tive was escape of current from the electrodes stimulating a few nerve fibres in
Control SOD 5 0 u ./ m l .
d-BRP
5 10
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Fig. 16 Superoxide dismutase ( SOD ) does not
potentiate the response of the donor BRP preparation 
( d-BRP ) to stimulation of its NANC nerves at the 
frequencies shown above each response with the 
failure to protect NANC ne uro tr ansmitt er  released 
from the d-BRP and acting on the test prepa ratio n 
( t-BRP ) to show any response. Flow rate of 6 ml. / 
ml. per minute was used. Stimu lation was by 0.5 ms. 
pulses at supramaximal voltage for 10 seconds. Tone 
was raised in both preparations by guan et hidine 10_5M 
in the Krebs' reservoir. Bioassay in a bath as in 
figure 4.
d-BR P
0 . 1  0 . 2  0 - 5  1 2 5 10 Hz
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Fig. 17 The response of the donor BRP ( d-BRP ) and 
the test BRP ( t-BRP ) preparat ions to field 
stimulation ( supramaximal voltage and 0.5 
millisecond' duration for 10 seconds at frequencies 
shown above ) in a bath ( Fig. 4 ). Tone was raised 
by 5-HT 10~5M .
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the test BRP muscle.
Therefore, experiments were designed to investigate this problem. First, if the 
relaxation of the test tissues was due to field stimulation of the NANC nerves of 
the test tissues, the rabbit aortic strip lacking such inhibitory nerves should show 
no response. If this inhibitory response in the test tissues was due to the action 
of the NANC inhibitory neurotransmitter, then assaying it also relaxes vascular 
smooth muscle, the test rabbit aortic strip should also relax. When the experi­
ment was repeated with both the BRP and a rabbit aortic strip simultaneously 
present as the test preparations, the rabbit aortic strip exhibited no response while 
the donor BRP and the test tissues ( BRP or rat anococcygeus muscle ) produced 
inhibitory relaxation ( Fig. 18 ). This result did not exclude the possibility that 
the relaxation of the test BRP or rat anococcygeus muscle was due to NANC 
neurotransmitter released from the donor BRP muscle since vascular muscle 
might not respond. A second experiment providing more direct evidence was 
therefore carried out. The donor BRP muscle was removed from the bath but 
leaving the electrodes, the other conditions were unchanged and the field stimula­
tion was repeated. The test BRP and rat anococcygeus muscles still relaxed as 
they did when the donor preparation had been present. Clearly this response 
could not be due to the NANC neurotransmitter release but must be due to 
current escape acting directly on the NANC nerves in the test preparations as 
shown in Figure 19. Another explanation of these results was the release of some 
other substances as a result of the field stimulation, for example Cl2 which was 
the product of electrolysis of the NaCl of the Krebs’ solution. If this was so and 
stimulation of the NANC nerves of the test preparations was unnecessary then 
tetrodotoxin ( 3x1 O^M ) or haemoglobin ( SxlO^M ) which blocks these nerves 
on the effect of the neurotransmitter should have no effect. This was tested. In
test rebbit aortic strip
1 J I I t
~ 1^  ■/ U» |* 11 •> —1| ( [, ,1>  ^Lf yl^ -1 <• ^
0 . 1 g
I I
t-BRP I \
0. 3g
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Fig. 18 The effect of field stimulation of the NANC 
nerves in a donor BRP ( d-BRP ) and two test 
prepara tio ns simultaneously present in the bath 
( Fig. 4 ). The test BRP ( t-BRP ) relaxes when the 
donor BRP is stimulated but there is no effect on the 
rabbit aortic strip. Stimulation was with 0.5 ms. 
pulses of supramaximal voltage for 10 seconds at the 
frequencies shown above each response. Tone was 
raised in all preparations with 5-HT ( 10_5H . ).
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the presence of either tetrodotoxin or haemoglobin the inhibitory relaxation of 
the test BRP and rat anococcygeus muscles was abolished ( Fig. 19 ). This 
result indicated the inhibitory relaxation of the test tissues was induced by stimu­
lation of NANC nerves in the test preparations by the current escape.
The results of all of these experiments simply conform previous efforts that it is 
not possible with bioassay even using superoxide dismutase to protect the puta­
tive NANC neurotransmitter to demonstrate the neurotransmitter release into the 
bath fluid and superfusate.
THE EFFECT OF SOME DRUGS ON THE NANC INHIBITORY RELAX­
ATION IN THE BRP AND THE RAT ANOCOCCYGEUS MUSCLE
An alternative approach to the identification of the NANC neurotransmitter is to 
study those drugs which mimic or abolish the inhibitory response. This method 
has been used with other traditional neurotransmitters, for example atropine in 
identifying cholinergic neurotransmission and ergot in adrenergic neurotransmis­
sion. The drugs already known to affect NANC neurotransmitter are haemoglo­
bin ( Bowman & Gillespie 1981; 1982a; 1982b; Bowman et al. 1982; ), 
methylene blue ( Bowman & Drummond 1984 ) and ethonal ( Gillespie et al. 
1981 ). None have identified the NANC neurotransmitter but haemoglobin has 
suggested there could be a relationship with EDRF. Recently there is evidence 
that EDRF is nitric oxide and may be synthesized from L-arginine by porcine 
aortic endothelial cells in culture ( Palmer et al. 1988a ). L-arginine is a physio­
logical precursor of endothelium-derived nitric oxide ( Palmer et al. 1988a;
0 . 1  0 . 2  0 . 5  1 5 10 H
t-BRP
( after d-BRP was removed )
\  \  \  \  \  \  \
TTX
0.3g
t-BRP ( after d-BRP was removed )
3m
Fig. 19 The effect of field stimulation in the 
presence ( upper record ) and after removal of the 
donor BRP preparation. The test BRP relaxes to field 
stimulation whether the donor BRP is presenc e in the 
electrodes or not. The lower record shows the effect 
of adding tetrodotoxin ( TTX ) 3 x 10-6M . to block
the NANC nerves in the test preparation. Field 
stimulation in the presence of TTX is no longer 
effective. Tone was raised by 5-HT 10~5M .
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Palmer et al. 1988b; Schmidt et al. 1988a; Schmidt et al. 1988b ).
THE EFFECT OF L-ARGININE ON THE NANC INHIBITORY RELAXA­
TION IN THE FRESH BRP MUSCLE
The experiments were designed to investigate whether L-arginine could poten­
tiate the NANC inhibitory response to field stimulation in the BRP muscles and 
therefore whether L-arginine is a physiological precursor of the NANC inhibitory 
neurotransmitter in the BRP muscles. If so this would strengthen the case for 
nitric oxide as the NANC inhibitory neurotransmitter.
Palmer et al. ( 1988a ) reported the vascular endothelial cells synthesized nitric 
oxide from L-arginine ( 1 to 10 pM. ) and the half-maximal effective concentra­
tion ( EC so ) of L-arginine was 3.5 +/- 0.1 pM while D-arginine ( 10 to 100 pM. 
) was without effect in the cultured porcine aortic endothelial cells. Falling on 
these experiments, the effects of L-arginine in concentrations from 10_5M. to 
SxlO^M. on the response of the BRP to NANC nerves stimulation have been 
examined.
Fresh BRP muscle strips were mounted in 10 ml. organ baths as shown in Fig. 3. 
The tone of the strips was raised by guanethidine ( 10~5M. ). The preparations 
produced NANC inhibitory relaxation induced by field stimulation at 0.1, 0.2, 
0.5, 1, 2, 5 and 10 Hz frequencies of supramaximal voltage, 20 pulses and 0.5 
milliseconds’ pulse duration. The results for two individual experiments are 
shown in Fig. 20 and Fig. 21. Dose-response curves of L-arginine on the 
response were studied and the results are shown for L-arginine 3xi0_sM. and 
3xKT*M. in Figure 22. The NANC inhibitory response was unchanged by
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3 x 1 0_4M
Fig. 20 The effect of L-arginine on the NANC 
inhibitory relaxation of fresh BRP prepara ti ons to 
field stimulation ( supramaximal voltage, 20 pulses 
and 0.5 milliseconds duration at frequencies shown 
above each response ). The upper records show the 
control response, the middle records are from the 
same experiment but after the addition of 3 x 10~5M . 
L-argin ine  and the-lower records again from the same 
experi men t in the presence of 3 x 10-4M . L-arginine. 
There is no potentiation of the response. Tone was 
raised by guanethidine 10_5M.
0.1 0.2 0.5 1 2 5 10 Hz
•  •  •  •  •
Co ntrol
O IR
Fig. 21 The effect of L-arginine on the NANC 
inhibitory relaxation of fresh BRP mus cles to field 
stimulation ( supramaximal voltage and 0.5 
millisecon ds  pulse duration for 20 pulses at 
frequencies shown above the response ). The upper 
records are the control, the lower from the same 
experiment but after the addition of 3 x 10~4M . 
L-arginine to the bath. In this experiment arginine 
increased the response at the three lower frequencies 
of stimulation. Tone was raised by guanethidine 
10-5M. in the bath.
100
Control
ARG. 3 x l 0 _4M .
ARG. 3 x 10-5M .
0 . 1 0 . 2 10 c•J 2 5 10
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Fig. 22 Shows the combined results of all
experiments without effects of L-arginine 3 x 10-5M . 
and 3 x 10_4M . on the response of fresh BRP to NANC 
nerve stimulation at the frequencies shown on the 
X-axis. The preparations were stimulated by field 
stimulation using 20 pulses at supramaximal voltages 
of 0.5 ms. pulse duration. Tone was raised with 
guaneth idi ne 10~5M . added to the bath. L-arginine had 
no effect on the response to field stimulation. 
Probability values are more than 0.05.
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addition of L-arginine 3xlO~5M, and 3xKT*M. ( Fig. 20 ). Occasionally L-arginine 
potentiated the inhibitory relaxation to field stimulation at low frequencies, such 
an experiment is in Fig. 21 where L-arginine 3xi0^M. potentiated the response at 
0.1, 0.2 and 0.5 Hz. However when all the results with L-arginine were com­
bined, no statistically significant effect on the NANC nerve stimulation in the 
BRP muscle was observed ( Fig. 22 ). At all concentrations of L-arginine the 
probability values are more than 0.05 on the frequency-response curves. 
Nevertheless though no single concentration produced a statistically significant 
effect, it was noticed that at all concentrations the frequency-response curves in 
the presence of L-arginine were somewhat shifted to the left compared with the 
control ( Fig. 22 ).
In the experiments described by Palmer et al. ( 1988a ) L-arginine ( 1 to 10 jiM. 
), but not D-arginine ( 10 to 100 pM. ), perfused through a column of porcine 
endothelial cells for 5 minutes before and continuing during a 5 minutes expo­
sure of the cells to bradykinin, increased the nitric oxide released from the cells. 
The cells were grown on culture on microcarrier beads and only if these cultured 
cells were washed three times and cultured for a further 24 hours in fresh culture 
medium without L-arginine, there was an enhancement of nitric oxide release 
observed. If the cultured cells were washed three times and cultured for a further 
24 hours in fresh culture medium containing L-arginine, the infusion of L- 
arginine had no effect on the release of nitric oxide in 11 out 16 experiments. 
The results indicated that only if endogenous L-arginine is deficient in the cul­
tured porcine endothelial cells will exogenous L-arginine be able to enhance the 
release of nitric oxide from the cells stimulated by bradykinin.
In the experiments with fresh BRP muscle preparations just dissected, it is
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unlikely that endogenous L-arginine is depleted or deficient in anyway. There­
fore, the likely explanation of failure of L-arginine to potentiate the NANC 
response to field stimulation of the BRP muscle was the presence of a sufficient 
supply of endogenous L-arginine for the nerves to synthesize the NANC inhibi­
tory neurotransmitter. If this store of L-arginine could be deplete then exogenous 
L-arginine might indeed potentiate the NANC response. Two methods were used 
on an attempt to produce this depletion. First continuous field stimulation was 
applied at high frequencies. The BRP muscle strips exhibited complete NANC 
inhibitory relaxation and for prolonged period up to one hour. This inhibitory 
relaxation of the guanethidine-induced tone during this stimulation at 5 Hz was 
maintained throughout the period of stimulation. Increasing the frequency from 5 
Hz up to 10, 20 or 40 Hz did not increase or decrease the inhibitory relaxation 
as shown in the upper records of Fig. 23. The results suggested that NANC inhi­
bitory nerves had a considerable resource in their synthetic capability and were 
not as easily depleted as some other autonomic nerves, for example adrenergic 
nerves.
Nevertheless it was possible that some decrease in the NANC neurotransmitter 
release did take place, but the quantity of the neurotransmitter was still sufficient 
to induce and maintain complete relaxation of guanethidine-induced tone. If the 
tone was raised by the addition of agonist, it might then be possible to see the 
effect on the neurotransmitter release by adding L-arginine. Such an attempt is 
illustrated in the lower records of Figure 23. Noradrenaline 10-6M raised tone 
but still L-arginine when added subsequently was without effect on the inhibitory 
response to NANC nerve stimulation. That the nerves remained effective is 
shown by the rapid restoration of the original tone when field stimulation was 
stopped.
10 20 40 Hz
5Hz
10-5
L-ARG. 
IQ’4 3 x 10 _4M
>1
NA
10-6M
Fig. 23 The upper penal shows the response of a 
pre paration of fresh BRP to continuous stimulation at 
5 Hz. At the close circle the frequency was 
pr og res siv ely raised to 10, 20 and 40 Hz. There was 
no evidence of ' escape ' of the inhibitory response. 
The lower records show the effect of continuous 
stimulation at 5 Hz during the period indicated by 
the bar. No radrenaline ( NA ) 10~6M . was added to 
raise tone. The subsequent addition of L-arginine 
10~5M. 10~4 M. and 3 x 10“4 M . did not increase the
response. Tone was raised with guanethidine 1Q~5M. 
added to the bath.
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These experiments suggest the NANC nerves have a considerable safety margin 
for neurotransmitter release and that either arginine is not an essential precursor 
for the neurotransmitter or that it is not possible sufficiently to deplete it to cause 
a reduction in neurotransmitter release below that safety margin.
This property of the NANC inhibitory nerves, their ability to induce and main­
tain complete relaxation of the retractor penis muscles for long periods, might be 
very important physiologically for the reproductive function since relaxation of 
these muscles is necessary for the erection of penis.
THE EFFECT OF L-ARGININE ON THE NANC INHIBITORY RELAXA­
TION OF THE COLD STORED BRP MUSCLE
Potentiation of the release of nitric oxide from endothelial cells can be shown 
only in cells cultured in the absence of arginine. An exhausted duplication of this 
experiment is not possible but it is possible to keep preparations alone and 
responding to nerve stimulation for several days by storing them at 4°C. At this 
temperature active uptake is abolished and it might be possible if the storage 
fluid was changed repeatedly to deplete the tissue of arginine. Such experiments 
were carried out with preparations of the BRP muscle. Tyrodes solution was 
used in these, experiments to avoid the problem of calcium precipitation. BRP 
muscles were cut into ten preparations and each put into sterile Tyrodes solution 
in tissue cultured vessels and kept at 4°C in a refrigerator for periods of 1 to 10 
days. Four BRP muscles were similarly treated so that each culture vessel con­
tained four preparations each from a different animal. When each vessel was 
eventually used these gave a sufficient number of preparations for the four chan­
nel polygraph pen recorder. The solution in each vessel was changed daily for
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fresh sterile Tyrodes to remove any L-arginine which had leaked from the 
preparations. The Tyrodes was sterilised by filtration through an 0.45 |im. filtra­
tion membrane. No antibiotics were applied because of the known effect of 
streptomycin on some nerve-muscle preparations. The NANC inhibitory 
responses of the preparations were studied at daily intervals from day 1 to day 
10. Details of the methods and arrangements were in METHODS AND 
MATERIALS and Fig. 2. The tone of the preparations was raised by guanethi- 
dine ( 10-5M ). The parameters of the field stimulation were 20 pulses, 
supramaximal voltage and 0.5 milliseconds at 0.1, 0.2, 0.5, 1, 2, 5 and 10 Hz 
frequencies.
The cold stored BRP preparations were mounted as shown in Fig. 3 and allowed 
to equilibrate for 60 to 90 minutes before experiments were begun. The addition 
of exogenous L-arginine ( 3xi0~5M ) had no effect on the NANC inhibitory relax­
ation at any time from day 1 to day 10. Further increase in the concentrations of 
exogenous L-arginine to 10“^ M and 3x1 O^M did not enhance the relaxation. None 
of these concentrations of L-arginine had any effect on the tone of the BRP 
preparations. The results are illustrated in Figure 24 to Figure 33. Occasionally 
in individual experiments some enhancement of the relaxation was observed ( 
Fig. 34 ). However when all results were combined neither potentiation nor inhi­
bition of the NANC inhibitory relaxation was visible nor was there any statisti­
cally significant effect though the dose-response curves of L-arginine group were 
often shifted to the left ( Fig. 35 to Fig. 38 ).
Cold storage of preparations of the BRP muscle produced a steady decline in the 
response to NANC nerve stimulation and the differences between control and 
any time after day 4 was statistically significant ( Fig. 39 ). The decay in the
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Fig. 24 The effect of L-argin ine on the response of 
BRP stored for one days to field stimulation of its 
NANC nerves. The upper records are the control, the 
lower two records are from the same experiment but 
after the addition of L-argin ine 3 x 10_5M. and 3 x 
10-4M . respectively. The NANC nerves were stimulated 
with 20 pulses at supramaximal voltage at 0.5 ms. 
pulse duration. Neither concentration of L-arginine 
increases the response to field stimulation. Tone was 
raised by guanethi dine 10~5M. added to the bath.
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Control • • » « « * «
3m
Fig. 25 The effect of L-a rginine on the response of 
BRP stored for two days to field stimulation of its 
NANC nerves. The upper records are the control, the 
lower two records are from the same experiment but 
after the addition of L-argin ine 3 x 10_5M. and 3 x 
l0~4M . respectively. The NANC nerves were stimulated 
with 20 pulses at supramaximal voltage at 0.5 ms. 
pulse duration. Neither con centr ation of L-arginine 
increases the respon se to field stimulation. Tone was 
raised by g ua nethid in e 10~5M. added to the bath.
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Fig. 26 The effect of L-arginine on the response of 
BRP stored for three days to field stimul ation of its 
NANC nerves. The upper records are the control, the 
lower two records are from the same experiment but 
after the addition of L-arginine 3 x 10_5M . and 3 x 
10~4 M . respectively. The NANC nerves were stimulate d 
with 20 pulses at supramaximal voltage at 0.5 ms. 
pulse duration. Neither concentration of L-argin ine 
increases the response to field stimulation. Tone was 
raised by guanethidine 10~5M. added to the bath.
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Fig. 27 The effect of L-arginine on the response of 
BRP stored for four days to field stimulation of its 
NANC nerves. The upper records are the control, the 
lower two records are from the same experiment but 
after the addition of L-arginine 10~5M . and 10-4M . 
respectively. The NANC nerves were stimulated with 20 
pulses at supr amaxima l voltage at 0.5 ms. pulse 
duration. Neither concentration of L-arginine 
increases the response to field stimulation. Tone was 
raised by guanethid in e 10~5M . added to the bath.
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Fig. 28 The effect of L-arginine on the response of 
BRP stored for five days to field stimul ation of its 
NANC nerves. The upper records are the control, the 
lower two records are from the same experim ent but 
after the addition of L-arginine 10~5M . and 10~4H . 
respectively. The NANC nerves were stimulated with 20 
pulses at supramaximal voltage at 0.5 ms. pulse 
duration. Neither con cen tration of L-arginine 
increases the response to field stimulation. Tone was 
raised by guanethidine 1G-5M . added to the bath.
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Fig. 29 The effect of L-arginine on the response of 
BRP stored for six days to field stimulation of its 
NANC nerves. The upper records are the control, the 
lower two records are from the same experiment but 
after the addition of L-arginine 10_5M . and 10~4M . 
respectively. The NANC nerves were stimulated with 20 
pulses at supramaximal voltage at 0.5 ms. pulse 
duration. Neither concent ration of L-argin ine
increases the response to field stimulation. Tone was 
raised by guan ethidine 10_5 M. added to the bath.
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Fig. 31 The effect of L-argin ine on the response 
of BRP stored for eight days to field stimulation of 
its NANC nerves. The upper records are the control, 
the lower two records are from the same experiment 
but after the addition of L-argin ine 3 x 10~5M . and 3 
x 1G-4M . respectively. The NANC nerves were 
stimulated with 20 pulses  at supramaxim al voltage at 
0.5 ms. pulse duration. Neither concentration of 
L-arginine increases the response to field 
stimulation. Tone was raised by guanethidi -n e 1G~5M. 
added to the bath.
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Fig. 32 The effect of L-arginine on the response of 
BRP stored for n i n e d a y s  to field stimulation of its 
NANC nerves. The upper records are the control, the 
lower two records are from the same experiment but 
after the addition of L-arginine 3 x 10-5M . and 3 x 
10~4 M . respectively. The NANC nerves were stimulated 
with 20 pulses at supramaximal voltage at 0.5 ms. 
pulse duration. Neither concentration of L-arginine 
increases the response to field stimulation. Tone was 
raised by gua nethidine 10_5M . added to the bath.
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Fig. 33 The effect of L-arginine on the response of 
BRP stored for ten days to field stimulation of its 
NANC nerves. The upper records are the control, the 
lower two records are from the same experiment but 
after the addition of L-arginine 3 x 10~5M. and 3 x 
10~4M. respectively. The NANC nerves were
stimulated with 20 pulses at supramaximal voltage at 
0.5 ms. pulse duration. Neither concentration of 
L- ar ginine increases the response to field 
stimulation. Tone was raised by guanethidine 10~5M. 
added to the bath.
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Fig. 34 The effect of L-ar gin ine on the response of 
BRP stored for eight days to field st imula tion of its 
NANC nerves. The upper records are the control, the 
lower three records are from the same experiment but 
after the addition of L- ar ginin e 3 x 10“5M . 10-4 M .
and 3 x 1G-4M. respectively. The NANC nerves were 
stimulated with 20 pulses at supr amaxi mal voltage at 
0.5 ms. pulse duration. Either concentr ation of 
L-arginine increases the response to field 
stimulation. Tone was raised by guane th idine 10-5M. 
added to the bath.
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Fig. 35 Shows the combined results of all
ex per iments on the effect of L-arginine 3 x 10~SM. on 
the response of the BRP to NANC nerve stimulation. 
All of these prep aration s had been cold stored for 
one day up to six days shown above. The pre parations 
were stimulated by field stimulation using 20 pulses 
at supramax imal voltag es of 0.5 ms. durati on and 
fr equenc ies shown above. Tone was raised with 
guanethi di ne  10_5M . added to the bath. L-argi nine has 
no effect on the response to field stimulation. All 
p ro ba bility  values are more than 0.05.
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Fig. 36 Shows the combined results of all
experiments on the effect of L-argini ne 3 x 10-5M . on 
the response of the BRP to NANC nerve stimulation. 
All of these pre pa ra tions had been cold stored for 
seven days up to ten days shown above. The 
preparations were stimulated by field stimulation 
using 20 pulses at supra maximal volt ages of 0.-5 ms. 
duration and fre quencies shown above. Tone was raised 
with gua net hidin e 10~5M. added to the bath. 
L-arginine has no effect on the response to field 
stimulation. All p r o b ab il ity values are more than 
0.05.
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Fig. 37 Shows the combined results of the
experiments on the effect of L-arginine 1G~4M. on the 
response of the BRP to NANC nerve stimulation. All 
of these pr eparations had been cold stored for 6, 8
and 10 days respectively shown above. The 
pr eparations were stimulated by field stimulation 
using 20 pulses at supramaximal voltages of 0.5 ms. 
duration and frequencies shown albove . Tone was raised 
with gu an eth idine 1Q-5M. added to the bath. 
L-arginine has no effect on the response to field 
stimulation. All probab ility values are more than 
0.05.
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Fig. 38 Shows the combined results of all
experiments on the effect of L-arginine 3 x 1G-4M . on 
the response of the BRP to RANG nerve stimulation. 
All of these prep arati ons had been cold stored for 6, 
7 and 8 days respective ly shown above. The 
p r epar at ions were stimulated by field stimulation 
using 20 pulses at supramaxim al voltages of 0.5 ms. 
duration and frequencies shown above. Tone was raised 
with guan et hidine  10-5M . added to the bath. 
L- ar ginine has no effect on the response to field 
stimulation. All p r o b a bility  values are more than 
0.05.
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RESULTS 5Q
response is unlikely to be the result of a diminished sensitivity of the smooth 
muscle cells since there was no corresponding decline in sensitivity to sodium 
nitrite ( Fig.. 40 ). If the decline was due to reduced NANC neurotransmitter 
release and this in turn due to a deficiency of precursor L-arginine then the later 
days of cold storage with the greatest decline in response should be the most 
suitable for testing the effect of exogenous L-arginine. An exception to this is 
day 10 where half the tissues tested no longer responded to field stimulation ( 
Table 1 ),
Table 1. The Effect of Cold Storage on the Proportion 
of Preparations Responding to Field Stimulation
Day of cold storage l 2 3 4 5 6  7 8 9  10
Preparations tested 12 12 12 12 12 12 12 12 12 12
Preparations responding 12 12 12 12 12 12 12 12 12 6
presumably because of anatomical disintegration of the NANC terminal nerve 
network. The effect of exogenous L-arginine 3xi0_5M was tested on a group of 
number for each day of cold storage over the ten day period ( Fig. 35 and Fig. 
36 ). In addition the higher concentration of lO^M was tested on a group of 
number for days 6, 8 and 10 ( Fig. 37 ) and a still higher concentration of 
SxlO^M L-arginine on days 6, 7 and 8 ( Fig. 38 ). None of these studies showed 
any significant effect of L-arginine on the NANC response.
The steady decline in the mean response to NANC nerve stimulation with 
increasing time of cold storage followed by a sudden failure of half the prepara­
tions to respond between the ninth day and the tenth day of storage prompted on
NaN02 10“5 3 x 1 0 - 5  1 0 - 4  3 x l 0 " 4 M
t-BRP on day 7
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Fig. 40 Shows the good re s p o n s i b i l i t y  of the cold 
stored BRP muscles to sodium ni tr ite on day 7 and day 
8 in a bath as shown in Fig. 4.
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investigation into the effect of cold storage on the motor adrenergic response and 
on the ability of guanethidine to induce an indirect sympathomimetic rise in tone. 
In the some ten day experiments the maximum motor response to field stimula­
tion at 10 Hz was tested followed by the addition of guanethidine to block these 
nerves and at the same time to raise tone by an indirect sympathomimetic 
action. The results are shown in Figure 41 and are similar to those for NANC 
nerve stimulation. For the first three day there was relatedly little change in 
response to adrenergic nerve stimulation, there was then a decline on day 4 and 
day 5 to a new level which was maintained with little further change up to day 9 
and the response to motor nerve stimulation on day 10 disappeared completely in 
all preparations. The rise in tone caused by guanethidine 10-5M was greater than 
the maximum response to adrenergic motor nerve stimulation averaging 15.6 +/- 
1.5 g. compared with 4.6 +/- 1.1 g. for nerve stimulation in fresh tissues. 
Nevertheless there was a similar pattern of change in the response to guanethi­
dine as was seen with motor nerve stimulation. Little change over the first three 
day, a decline between day 4 and day 5 to a level which was fairly well main­
tained until day 9 followed by a substantial decline between the ninth day and 
the tenth day. Unlike nerve stimulation some response to guanethidine was how­
ever still obtained on the tenth day. These results are consistent with the previous 
suggestion for NANC nerves that after the first three or four days there is a 
decline in NANC neurotransmitter output and quite suddenly between the ninth 
day and the tenth day there is anatomical disintegration of the nerve network. 
The continuing ability of guanethidine to produce a response on the tenth day 
suggests some stores of noradrenaline still exist in nerves in the tissue. The ina­
bility of nerve stimulation at this time to produce a response suggests the nerve 
action potential can no longer propagate into these store, a situation consistent 
with breaks appearing in the physical connection of the terminal nerve network.
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THE EFFECT OF L-NMMA AND D-NMMA ON THE NANC INHIBI­
TORY RELAXATION OF THE BRP MUSCLE AND THE RAT ANO- 
COCCYGEUS MUSCLE
Endothelium-derived relaxing factor ( EDRF ) is almost certainly nitric oxide ( 
Palmer et al. 1987 ) and L-arginine appears to be its physiological precursor ( 
Schmidt et al. 1988a; Schmidt et al. 1988b; Palmer et al. 1988a; Palmer et al. 
1988b ). Furthermore the substrate specificity for nitric oxide synthesis appears 
to be restricted to L-arginine ( Palmer et al. 1987; Palmer et al. 1988a; Schmidt 
et al. 1988a ). Nitric oxide is synthesized by L-arginine-utilizing enzymes from 
the terminal guanidino nitrogen atom(s) of L-arginine ( Palmer et al. 1988a; Pal­
mer et al. 1988b; Schmidt et al. 1988b). L-monomethyl-N-arginine ( L-NMMA 
), a competitive inhibitor of L-arginine-utilizing enzymes, but not D- 
monomethyl-N-arginine ( D-NMMA ), inhibited both the generation of nitric 
oxide by endothelial cells in culture and the endothelium-dependent relaxation of 
rabbit aortic rings. These effects were dose-dependently competitively reversed 
by L-arginine. The inhibitory effect of L-NMMA ( 0.3 to 10.0 pM. ), but not D- 
NMMA ( 10.0 to 100.0 pM.), on nitric oxide release from the cultured 
endothelial cells was concentration-dependent manner ( IC50 3.0 +/- 0.7 pM. ) 
and was reversed by L-arginine ( 30 pM. ). Also the endothelium-dependent 
relaxation of rabbit aortic rings was inhibited by L-NMMA ( 3 to 300 pM. ) 
again in a concentration-dependent manner with 50 % inhibition by L-NMMA 
30 pM. and 64 % by L-NMMA 300 pM. of the relaxation induced by 1 pM. ace­
tylcholine ( Palmer et al. 1988b ). These results suggested that inhibition by L- 
NMMA or its reversal by L-arginine on nitric oxide release from cultured 
endothelial cells or endothelium-derived relaxation in rabbit aortic rings did not 
need high concentrations of L-NMMA or L-arginine respectively.
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The NANC inhibitory neurotransmitter in the BRP muscle and the rat anococ- 
cygeus muscle, and the inhibitory factor extracted from the BRP muscle have 
many properties in common with EDRF and nitric oxide, for example, they 
induced inhibitory relaxation in many smooth muscles by stimulation of 
guanylate cyclase and increase of cGMP content on these tissues, and their 
effects could be abolished by haemoglobin ( Gillespie et al. 1981; Bowman et al. 
1982; Bowman & Drummond 1984; Griffith et al. 1984 ). If the NANC inhibi­
tory neurotransmitter in these tissues is nitric oxide and its precursor is L- 
arginine, L-NMMA but not D-NMMA should inhibit the NANC inhibitory relax­
ation and L-arginine should reverse this effect in both the BRP muscle and the 
rat anococcygeus muscle.
The experiments reported here were intended to investigate the effect of L- 
NMMA and D-NMMA in the BRP muscle and the rat anococcygeus muscle and 
particularly to see whether L-NMMA specifically blocked the NANC inhibitory 
relaxation and if so, could L-arginine reverse this effect. A positive finding 
would suggest L-arginine as a physiological precursor of the NANC inhibitory 
neurotransmitter and reinforce the possibility of nitric oxide as the NANC inhibi­
tory neurotransmitter.
THE EFFECT OF L-NMMA AND D-NMMA ON THE BRP MUSCLE
Fresh BRP muscle preparations, 10 to 20 mm. in length and 1.5 to 2 mm. in 
width, were mounted as Fig. 3. The investigation was to study the effect of L- 
NMMA on the tone of the BRP muscle induced by guanethidine ( 10~5M ) and 
on the NANC inhibitory relaxation induced by field stimulation ( supramaximal 
voltage, 0.5 milliseconds’ pulse duration at 0.1, 0.2, 0.5, 1, 2, 5 and 10 Hz
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frequencies for 20 pulses ). In each experiment control NANC inhibitory 
frequency-response curves were constructed before treatment with L-NMMA and 
repeated after 10 minutes’ exposure and in the continuing presence of L-NMMA. 
Concentrations from 3xi0”5M up to 10_3M L-NMMA were studied.
At the final concentrations of 3xl0_5M, lO^M and SxlO^M, L-NMMA was 
without any significant effect on the tone induced by guanethidine or the NANC 
inhibitory relaxation induced by field stimulation. The results for a single exper­
iment are illustrated in Fig. 42. When all the results with these three concentra­
tions of L-NMMA were combined, there was no significant difference between 
the control and the drug-treated frequency-response curves as shown in the left 
of the Fig. 43. Since these concentrations of L-NMMA were greater than those 
used to inhibited nitric oxide production from cultured endothelial cells, these 
results were interpreted as negative and it was assumed L-NMMA had no inhibi­
tory effect on NANC inhibitory relaxation in the BRP muscle. After the experi­
ments with the rat anococcygeus muscle in which it was quite clear that L- 
NMMA did inhibit NANC inhibitory relaxation, the BRP was re-examined with 
the higher concentration of 10~3M. L-NMMA. The results from a single illustra­
tion are shown in Fig. 44 and for all experiments shown in the right graph of 
the Fig. 43. The higher dose of L-NMMA had two effects, first it caused a 
further rise in tone and secondly it reduced the response to NANC nerve stimula­
tion. Both effects are visible in the experiment illustrated in Fig. 44. The increase 
in tone arranged 24.5 % of that originally induced by guanethidine and the inhi­
bition of the NANC response, which was maximal at 16.7 +/- 4.6 % to 5.6 +/- 
2.1 % reduction at 0.2 Hz. Both effects of L-NMMA were partially reversed by 
10_3M. L-arginine and the subsequent magnitude of the response at 0.2 Hz, 12.1 
+/- 3.3 % was not significantly difference from the control. These results show
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Fig. 42 Shows at con centra ti ons of 3 x 10~5M . and 
l U - ^ M . L-m ono me thyl-N- ar ginine ( L- NMM A ) had no 
effect on inhibitory relaxation of the BRP muscle to 
NANC nerve stimulation by s u pra ma ximal voltage and 
0.5 ms. pulse duration at frequen cies shown above 
each response for 20 seconds.
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Fig. 44 The effects of a high concentration of 
10~3M . L - m o n o m e th y 1-N-argin ine ( L-NMMA ) on the tone 
of and the NANC inhibitory relaxation of the BRP 
muscle induced by field stimulation ( supramaximal 
voltage and 0.5 ms. pulse duration for 20 pulses at 
freque nci es shown above each response ). L-NMMA
produces a small inhibitory effect on NANC nerve 
response specially at lower frequencies of 0.2 and 
0.5 Hz. L - NMM A 10~3M . causes a partial reversal of 
this inhibition.
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that while L-NMMA is not as effective in inhibiting NANC inhibitory relaxation 
in the BRP muscle as it is in the rat anococcygeus muscle ( compare Fig. 42, 
Fig. 43 and Fig. 44 with Fig. 45 and Fig. 46 ), it can at higher concentrations 
cause both the rise in tone and inhibiting the NANC response especially at low 
frequencies.
THE EFFECT OF L-NMMA ON THE NANC INHIBITORY RELAXATION 
OF THE RAT ANOCOCCYGEUS MUSCLE
The rat anococcygeus muscle was first discovered and introduced as a very good 
example of an NANC innervated muscle preparation by Gillespie ( 1972 ) and 
has many properties on the NANC inhibitory relaxation in common with the 
BRP muscle ( Gillespie 1972; Gillespie 1980; Gillespie & Martin 1980; Bowman 
& Gillespie 1982 ). The retractor penis muscle is a continuation of the anococ­
cygeus muscle ( Gillespie & Martin 1980; Gillespie 1987 ). It would be expected 
therefore that the innervation and neurotransmitter in the both muscles would be 
the same. To check this the effect of L-arginine and L-NMMA on NANC inhibi­
tory neurotransmission in the rat anococcygeus was examined.
Fresh rat anococcygeus muscles were mounted as Fig. 3. The effect of L- 
NMMA, D-NMMA and the reversion of the effect of L-NMMA by L-arginine 
on the response to NANC nerve stimulation were studied. Similar frequencies of 
stimulation and stimulation conditions were used as were used for the BRP and 
tone was raised with guanethidine 10_5M. Control frequency-response curves of 
NANC relaxation were constructed and compared with similar curves in the 
presence of L-NMMA or D-NMMA at final concentrations at 1(T5M, 3xiO~5M, 
lO^M and 3xl0^M, and finally the ability of L-arginine to reversed the effect of
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L-NMMA was examined.
L-NMMA had two effects on the rat anococcygeus; first it caused an immediate 
rise in tone and secondly it produced a dose-related inhibition of the response to 
NANC nerve stimulation. An experiment illustrating the inhibition of the nerve 
response is showed in Fig. 45. L-NMMA 10"5M. inhibits the response at all fre­
quencies of stimulation and this effect increases with dose up to Sxio^M. The 
results for all the experiments at four dose levels of L-NMMA are shown in Fig. 
46. The inhibitory response is significantly inhibited at the probability < 0.01 
level or better at all doses ( except the responses at 0.1 Hz ). The effect of 
3x1 O^M. L-NMMA is not significantly different from that of 10^M L-NMMA 
presumably represents the maximum inhibitory effect. This inhibitory action was 
rapidly reversed by washing ( Fig. 47 ). This inhibitory property of L-NMMA 
was not possessed by its D isomer which consistently and in even higher doses 
had no effect on the response to NANC nerve stimulation. An experiment illus­
trating this point is shown in Fig. 48 and the Fig. 49 summarises all the results 
with D-NMMA in concentrations up to 3x10"%!. The effect of L-NMMA was 
therefore stereoselective. If the mode of action was as a competitive inhibitor of 
endogenous L-arginine then high exogenous concentrations of L-arginine might 
be expected to reverse the inhibition. This was tested and illustrative results from 
a single experiment are shown in the upper three records of the Fig. 50 and a 
summary graph of all the results in Fig. 51. In Fig. 50 L-NMMA 10^M. causes 
an immediate rise in tone together with about 70 % inhibition of the response to 
NANC nerve stimulation. The addition of L-arginine 3x10"^. reverses the rise in 
tone and at some time produces a partial restoration of the nerve stimulation. The 
lower records in Fig. 50 show that these effects are not due to an enhanced sen­
sitivity to nitric oxide which in the presence of even SxlO^M. L-NMMA is
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Fig. 45 L - m o n o m e t h y 1 - N - a r g i n i n e  ( L-NMMA ) inhibits 
the inhibitory relaxation of the rat anococcygeus 
muscle to NANC nerve stimulation in a dose-dependent 
manner at c o ncentrations of 10~5M. up to 3 x 10~4M . 
Stimulation was by supramaximal voltage and 0.5 ms. 
pulse duration for 20 pulses at frequencies shown 
above each r e s p o n s e .
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Fig. 47 L-monomethyl-N-arginine ( L-NMMA ) raises the 
tone of and inhibits the inhibitory relaxation of the 
rat anococcygeus muscle to NANC nerve stimulation at 
c oncentration of 10~4 M . and these effects are 
reversed by washing out L-NMMA as shown in the upper 
three records. Stimulation was by supramaximal 
voltage and 0.5 ms. pulse duration for 20 pulses at 
frequencies shown above each response. The lowest 
records also show L-NMMA dose-dependently raises the 
tone of the rat anococcygeus muscle before the tone 
raised by agonist, an effect reversed by L-arginine.
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Fig. 48 Shows 'D-monometh y 1 - N - a r g i n i n e  ( D-NMMA ) is 
without effect on i n h i bitory r e l a x a t i o n  of the rat 
anococcygeus muscle to NANC n e r v e  stimulation at 
c o ncentrations from 10-5M . up to 3 x 10_4 M . compared 
with L-NMMA 10_4M . does inhibit the relaxation shown 
in the lowest records. F i eld s t i m u l a t i o n  was by 
supramaximal voltage and 0.5 ms. p u l s e  duration for 
20 pulses at frequencies shown above each response.
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Fig. 50 L - m o n o m e t h y l - N - a r g i n i n e  ( L-NMMA ) raises 
the tone of and inhibits the inhibitory relaxation of 
the rat a n o c o c c y g e u s  muscle to NANC nerve stimulation 
at c o n c e n t r a t i o n  of 10~4 M . and these effects are 
p a r t i a l l y  reversed by 3 x 10~4M . L-arginine as shown 
in the upper three records. Stimulation was by 
supra m a x i m a l  v o l tage and 0.5 ms. pulse duration for 
20 pulses at frequencies shown above each response. 
The lowest records show 3 x 10_4M . L-NMMA does not 
inhibit the d o s e - d e p e n d e n t  relaxation induced by 
nitric oxide in the rat anococcygeus muscle.
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unchanged. The frequency-response curve in Fig. 51 show the inhibitory effect 
of 10-5M. L-NMMA is almost competitively reversed by L-arginine 3xlO-5M. and 
the greater inhibition by KrM . L-NMMA is reduced by about 50 % by L- 
arginine 3x1 O^M. Some additional experiments were performed adding mixtures 
of L-arginine and L-NMMA. The results of these are illustrated in Fig. 52 and 
Fig. 53. At both doses of 10~5M. and lO^M. L-NMMA an appropriate competi­
tive concentration of L-arginine completely prevented the inhibitory effect on the 
response to NANC nerve stimulation.
The second effect of L-NMMA on the rat anococcygeus muscle was to cause a 
further rise in tone. This is illustrated in Fig. 47, Fig. 48 and Fig. 50. The effect 
begins after a short talent period of less than a minute and develops quite rapidly 
to a new and well maintained plateau of tone. This effect was dose dependent 
from 1 g ( 10 % ) at 10“5M; 1.4 g ( 14 % ) at 3xi0“5M; 1.7 g ( 17 % ) at lO^M 
and 2 g ( 20 % ) at SxlO^M and was easily reversed by washing out the L- 
NMMA. The rise in tone was also reversed by L-arginine ( Fig. 50 ). These 
results are consistent with a basal release of the NANC inhibitory neuro­
transmitter and at least some similar relaxant with a similar origin in L-arginine 
as shown in lower records in Fig. 47.
The effects of L-NMMA, D-NMMA and the reversal of L-NMMA by L-arginine 
were also studied on the release of EDRF from rabbit aortic rings with their 
endothelium intact. These experiments were original intended as controls to 
demonstrate that L-NMMA did indeed inhibit an arginine-dependent process. 
Such controls were required after the first series of the experiments on the BRP 
where L-NMMA had no effect. The need for such controls diminished after 
successfully demonstrating the action of L-NMMA on the rat anococcygeus.
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Fig . 52 The inhibition of L - m o n o m e t h y l - N - a r g i n i n e  
( L-NMMA ) 10~4M. on rat a n o c o c c y g e u s  NANC inhibitory 
relaxation is prevented by 3 x 10~4 M . L-arginine 
( L-ARG. ) added s i m u l t a n e o u s l y  with L-NMMA. 
Stimulation was by supramaximal voltage and 0.5 ms. 
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Rings of about 2 mm. width were cut from rabbit thoracic or abdominal aortae, 
then each ring cut through to produce an open strip which was then mounted on 
a hook in a 10 ml. organ bath. Tone was raised by adding phenylephrine 
7.5x10"^. and once the raised tone had stabilised, EDRF was released by adding 
acetylcholine to the bath. As Fig. 54 illustrates, D-NMMA in concentration up to 
3xKT*M. had no effect on the response whereas L-NMMA in concentrations 
from 3xio~5M. to KTWL caused a dose related inhibition of the response to 
EDRF. The effect of L-NMMA lO^M. was easily reversed by washing out L- 
NMMA or by L-arginine 3x1 O^M. When L-NMMA and L-arginine in appropri­
ate doses were added simultaneously, the effect of L-NMMA was prevented ( 
Fig. 54 ). Just as in the rat anococcygeus this effect of L-NMMA was not due to 
a reduced effectiveness of EDRF since the dose-response relationship for nitric 
oxide induced relaxation was unaltered by the presence of L-NMMA lO^M. ( 
Fig. 54 ).
THE EFFECT OF L-CANAVANINE ON THE NANC INHIBITORY 
RELAXATION OF THE BRP MUSCLE AND THE RAT ANOCOC­
CYGEUS MUSCLE
The rat anococcygeus muscle is much more sensitive to L-monomethyl-N- 
arginine than the bovine^ retractor penis muscle. There are three possible explana­
tions. First and most likely assumes the NANC inhibitory neurotransmitter in 
both tissues is the same but its physiological precursor is either not L-arginine or 
not exclusively L-arginine. Secondly, the NANC inhibitory neurotransmitter and 
its precursor are the same in both tissues but the enzymes which synthesize the
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neurotransmitter are not and have different sensitivity to L-monomethyl-N- 
arginine. Thirdly, the NANC inhibitory neurotransmitter might be different in the 
two tissues.
L-canavanine, a guanidinooxy structural analogue of arginine and an inhibitor of 
various L-arginine-utilizing enzymes, was reported to inhibited the endothelium- 
dependent relaxation of rat thoracic aortic rings induced by ATP and acetylcho­
line ( Schmidt et al. 1988a ) and to abolish basal and ATP-induced nitric oxide 
formation and release ( Schmidt et al. 1988b ). Iyengar et al ( 1988 a ) demon­
strated an L-arginine-dependent biosythesis of nitrite, nitrate and, when morpho- 
line was presented, N-nitrosomorpholine by cultured macrophages; the nitrogen 
of the nitric oxide moieties was derived from the terminal guanidino nitrogen of 
arginine. L-arginine inhibited the formation of these NO-containing compounds. 
Therefore L-canavanine might through some light on these possibilities so that 
its effect on the NANC inhibitory relaxation of the bovine retractor penis muscle 
and the rat anococcygeus muscle was examined.
Bovine retractor penis muscle preparations or rat anococcygeus muscle prepara­
tions were mounted as Fig. 3. The tone of the muscles was raised by guanethi- 
dine ( 10-5M ). The inhibitory relaxation was induced by field stimulation ( 
supramaximal voltage and 0.5 milliseconds’ pulse duration at 0.1, 0.2, 0.5, 1, 2, 
5 and 10 Hz frequencies for 20 pulses ).
In the BRP L-canavanine exhibited no inhibitory effect on the NANC inhibitory 
relaxation induced by field stimulation at concentrations of 3xiO_5M, lO^M up to 
3xl0^M. as shown in Fig. 55 from a single experiment and a summary of all the 
experiments shows in Fig. 56. But at very high concentration ( 10~3M ), L-
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Fig. 55 L-canavanine ( L - C A N . ) does not inhibit 
the NANC inhibitory relaxation of the BRP muscle to 
the nerve stimulation at concentration of 3 x 10 -4M 
Stimulation was by supramaximal voltage and 0.5 ms. 
pulse duration for 2C) pulses at. frequencies shown
i above each r e s p o n s e .
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canavanine inhibited the NANC inhibitory relaxation, an effect partially reversed 
by L-arginine 10“3M. as shown in Fig. 57 from a single experiment and in Fig. 
58 for the summary of these experiments.
In rat anococcygeus muscle, L-canavanine was without effect on the 
guanethidine-induced tone of the rat anococcygeus muscle and the NANC inhibi­
tory relaxation induced by field stimulation at concentrations from 3xl0“5M. up to 
2xlO"3M. and pretreatment even for two hours as shown in Fig. 59 from a single 
experiment and in Fig. 60 for the summary of all the experiments.
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Fig. 57 High concentration of 1Q_3M. L - c a n a v a n i n e  
( L-CAN. ) inhibits the inhibitory relaxation of the 
BRP muscle to NANC nerve stimulation, an effect 
p a r t i a l l y  reversed by 10_3M. L-arginine ( L-ARG. ). 
S t i m ulation was by supramaximal voltage and 0.5 ms. 
pulse d u r a t i o n  for 20 pulses at frequencies shown 
above each response.
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Fig. 59 L - c a n avanine ( L-CAN. ) does not inhibit 
NANC inhibitory r e l a xation of the rat anococcygeus 
muscle to the nerve s t i m u l a t i o n  at concentrations 
from 3 x 10-5M . up to 2 x 10-3M . Field stimulation 
was by supramaximal v o l t a g e  and 0.5 ms. pulse 
d u r a t i o n  for 20 pulses at frequencies shown above 
each response.
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DISCUSSION
The initial objective of this project was to try to detect by bioassay the non- 
adrenergic non-cholinergic inhibitory neurotransmitter released from the bovine 
retractor penis muscle by field stimulation. The BRP has a dense NANC innerva­
tion and many properties of neurotransmission by these nerves are known 
nevertheless the neurotransmitter remains a mystery which has defied all attempts 
to identify chemically its nature ( Klinge et al. 1970; Klinge & Sjostrand 1974; 
Ambache & Killick 1978; Bowman & Gillespie 1981; Gillespie et al. 1981; 
Bowman et al. 1982b; Bowman & Drummond 1984 ). If the NANC neuro­
transmitter could be detected biologically, then it might be possible to isolate, 
extract and purify it, which should make identification a relatively simple matter. 
Even if isolation was not possible a variety of experiments on its properties and 
interaction with drugs would be possible as was done with EDRF experiments 
which would through new light on the nature of the NANC neurotransmitter. 
Unfortunately this initial objective was without success. A second approach to 
the identification of the NANC neurotransmitter was to study the effect of drugs 
which are known to potentiate or block effects of potential neurotransmitters 
such as the inhibitory factor from the BRP and EDRF, both of which possess 
many properties in common with the NANC inhibitory neurotransmitter. This 
was the second objective of this project.
Like many smooth muscles the mechanical function of the BRP requires both an 
excitatory and inhibitory innervation. Since Sertoli ( 1883 ) first studied the 
retractor penis muscle of several species both in vitro and in vivo, many reports
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have appeared on this subject ( Langley & Anderson 1895; Oppenheimer 1938; 
Goldenberg 1965; Luduena & Grigas 1966; 1972; Klinge 1970; 1972a ). The 
main points to emerge from this work are first to confirm the existence of a 
powerful excitatory and inhibitory innervation. The excitatory innervation 
appeared to be classically adrenergic in so far as the nerves had their origins 
from the lumbar sympathetic spinal cord. Most of the preganglionic fibres travel 
to the paravertebral sympathetic chains, synapse in the sacral ganglia of the sym­
pathetic chain and then the postganglionic fibres are distributed via the pudic 
nerve to the muscle. Some of the fibres reach the target via the hypogastric nerve 
and a few follow the pelvic parasympathetic nerve. The excitatory neuro­
transmitter of these sympathetic fibres is noradrenaline. The inhibitory innerva­
tion in contrast has its origin in the sacral spinal cord and the neurotransmitter is 
unknown. While readily blocked by TTX, adrenergic or cholinergic blocking 
agents were without effects on the NANC inhibitory response. In 1974 Klinge 
and Sjostrand systematically studied the physiology and pharmacology of the 
BRP. They verified and extended these results. The excitatory contraction was 
induced by noradrenaline and mediating by excitatory a-adrenoceptors. The con­
traction evoked by transmural stimulation were abolished or profoundly 
depressed by adrenergic neuron blocking agents or a-adrenoceptor blocking 
agents and augmented by inhibitors of neuronal noradrenaline uptake. Also the 
retractor penis was induced to contract by the indirectly acting sympathomimetic 
amine tyramine.
While tetrodotoxin and local anaesthetics abolished the inhibitory response to 
field stimulation of the BRP confirming the neural nature of the response, acetyl­
choline and pilocarpine contracted rather than relaxed the BRP and these con­
tractions were inhibited by atropine and scopolamine. The muscarinic receptors
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accessible to exogenous cholinomimetics appeared therefore to be excitatory in 
the BRP. The inhibitory response to field stimulation of the BRP was not 
affected by physostigmine, atropine, scopolamine, ganglionic or neuromuscular 
blocking agents. The inhibition was also unimpaired by hemicholinium and botu- 
lium toxin. These suggest the inhibitory response to field stimulation of the BRP 
is not due to the release of acetylcholine from the inhibitory nerves.
Although PGE i relaxed the retractor penis at low concentration and was sug­
gested as the inhibitory neurotransmitter ( Luduena & Grigas 1972 ), the inhibi­
tory response to field stimulation was uninfluenced by inhibitors of prostaglandin 
synthesis ( Klinge & Sjostrand 1974 ).
ATP, ADP and AMP contracted the retractor penis. Many nucleosides and 
nucleotides were without effect or had a weak contractile effect on the retractor 
penis. These suggest the inhibitory neurotransmitter is unlikely purinergic ( 
Klinge & Sjostrand 1974 ).
Histamine, 5-HT, bradykinin and Substance P contracted the retractor penis. The 
inhibitory response to field stimulation was unaffected by antihistamines and 5- 
HT antagonists ( Klinge & Sjostrand 1974 ).
Posterior pituitary hormones, GABA, glycine, glutamic acid, aspartic acid and 
several other amino acids were without effects on the retractor penis.
This inability to mimic the effect of NANC nerve stimulation excludes many 
substances as potential NANC inhibitory neurotransmitter.
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THE BIOASSAY DETECTION OF THE NANC NEUROTRANSMITTER
One of the prime requirements for a substance as a neurotransmitter is its release 
by nerve stimulation. If the NANC neurotransmitter could be detected by a test 
tissue after liberation by field stimulation, this requirment would have been met. 
It would also provide a starting point for more extensive study of its properties. 
Several manipulations of the standard Loewi-type experiment were tried in the 
hope of detection of the NANC inhibitory neurotransmitter. For example having 
failed with donor preparations of standard size, large donor BRP’s were used in 
the hope of increasing the amount of neurotransmitter released. When this failed, 
thinner donor BRP was used to improve the diffusion of the neurotransmitter 
into the bath fluid. On the assay preparation side both rat anococcygeus and rab­
bit aortic strip were used in the hope that one or other would be the most sensi­
tive detection system. Also many changes in the parameters of field stimulation 
were used including frequencies from 0.1 Hz up to 128 Hz, different duration of 
field stimulation from 10 seconds up to 120 seconds, even continuous stimulation 
for 60 minutes at frequencies from 5 Hz up to 40 Hz. But all these attempts 
were without success ( Fig. 8 & Fig. 9 ). In these experiments the donor BRP 
exhibited different degree of relaxation to stimulation from almost no relaxation 
at 0.1 Hz to complete relaxation maintained for the duration of stimulation at 
high frequencies. This graded response is presumably due to the graded release 
of neuro transmitter from the donor BRP. The most likely situation in which to 
detect neurotransmitter release would be while the donor BRP exhibited continu­
ous complete relaxation. Nevertheless even in these circumstances the experi­
ments failed. Possible explanations for this failure were first and most likely that
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the half-life of the neurotransmitter is so short that it is all destroyed during 
diffusion to the bath fluid. Secondly it may reach the bath fluid but is so diluted 
as to be below the level of detection of the test tissues. The open cascade system 
( Fig. 5 ) which greatly reduces this dilution was used to try to overcome this 
last problem. The flow rates of superfusion varied from 0.5 up to 15 ml. per 
minute. These gave a wide range of dilutions but still the test tissues failed to 
detect the neurotransmitter although changes in frequencies and duration were 
also applied and in spite of donor BRP exhibiting very powerful relaxation to 
field stimulation.
In this laboratory Gillespie et al. ( 1988 ) successfully detected EDRF released 
from rabbit aortic endothelium by using an improved closed cascade as illus­
trated in Fig. 6 whereas the system illustrated in Fig. 4 was not successful. Since 
the response to EDRF and to NANC field stimulation share many properties such 
as mediation by stimulation of guanylate cyclase and increasing the level of 
cGMP and block by haemoglobin and methylene blue, a system successful for 
EDRF might also for NANC neurotransmitter. This was tried but again failed in 
spite of many variations in the size of the donor BRP, the frequency, the dura­
tion of stimulation and the rate of flow. Because Gillespie et al. ( 1988 ) success­
fully detected EDRF released from endothelium in the similar cascade using rela­
tively high flow rates of 4 to 7 ml./min., it is unlikely that flow rates other than 
those tested would have made it possible to detect the NANC neurotransmitter. 
That it was not the conditions of the experiment but rather the nature of the 
NANC neurotransmitter which was the problem was suggested by the successful 
demonstration of the release of the neurotransmitter noradrenaline by field stimu­
lation of the motor nerves. These results demonstrate the possibility of releasing 
neurotransmitter from this donor tissue and detecting it with suitable test tissues.
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Another possible explanation for failure to detect the NANC neurotransmitter is 
the presence of a powerful inactivation system in the muscle. This could either 
be an uptake system or enzymatic destruction. In the detection of noradrenaline 
the Krebs’ solution was always newly made up with deionised distilled water 
and sometime with addition of EDTA lO^M. and ascorbic acid 10-5M. While 
these manoeuvres would very successfully protect noradrenaline from chemical 
destruction, no special measures were required either to block neuronal uptake or 
the enzymes MAO and COMT. Since both the chemical nature of the NANC 
neurotransmitter and its method of inactivation are still unknown, it is difficult to 
know how to protect against either chemical destruction or biological inactiva­
tion. Nevertheless as the NANC response to field stimulation has many proper­
ties in common with EDRF which is readily oxidized by the superoxide anion ( 
Gryglewski et al. 1986; Rubanyi & Vanhoutte 1986 ), the possibility that 
superoxide dismutase would both potentiate the response to NANC nerve stimu­
lation and made it possible to detect the protected neurotransmitter was investi­
gated but again without success.
In general from all the above results, the most probable reason for the failure to 
detect the NANC inhibitory neurotransmitter by bioassay is the very short half- 
life of the neurotransmitter rather than a deficient amount of the neurotransmitter 
released from the donor BRP. The amount of the neurotransmitter released from 
the donor BRP at high frequencies of continuous stimulation which produced 
complete relaxation throughout the stimulation period with no evidence of " 
escape " should have been suitable for the detection of the neurotransmitter if the 
neurotransmitter was not rapidly destroyed.
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THE EFFECT OF SUPEROXIDE DISMUTASE ON THE NANC INHIBITORY 
RESPONSE
EDRF is very unstable with a half-life of between 6 seconds ( Griffith et al. 
1984; Cocks et al. 1985 ) and 50 seconds ( Forstermann 1985 ). Rubanyi & 
Vanhoutte ( 1986 ) investigated the effects of oxygen-derived free radicals on the 
production and biological activity of endothelium-derived relaxing factor released 
by acetylcholine. Rings of canine coronary arteries without endothelium ( bioas­
say rings ) were superfused with solution previously passed through a canine 
femoral artery with endothelium. They found superoxide dismutase caused maxi­
mal relaxation of the bioassay ring when injected beyond the donor femoral 
artery and doubled the half-life of the EDRF. This protective effect of the 
enzyme was augmented fivefold by lowering the oxygen content of the perfusate 
from 95 % to 10 % . They believed superoxide anion inactivated the relaxing 
factor released by acetylcholine from endothelial cells, an effect favoured by 
hyperoxia. About the same time Gryglewski et al. ( 1986 ) reported EDRF 
released from vascular endothelial cells cultured on microcarrier beads and bioas­
sayed using a cascade of superfused aortic smooth muscle strips was protected 
from breakdown by superoxide dismutase. They concluded that the superoxide 
anion contributed to the instability of EDRF. Apps & Hamden ( 1985 ) indicated 
superoxide anion was degraded as follow,
2 0 2 + 2 H +   SOD — —  H2P 2 + 0 2
2 H 20 2 --------  catalase — 2 H 20  +  0 2
In spite of EDRF possessing many properties in common with the NANC 
response to nerve stimulation, superoxide dismutase did not potentiate the inhibi­
tory response to NANC nerve stimulation in the BRP in concentrations from 10 
u./ml. up to 400 u./ml. ( Fig. 14, Fig. 15 & Fig. 16 ). It could be however the
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neuromuscular junctions of the NANC nerves were very narrow so that the time 
available for superoxide anion to destroy the neurotransmitter was too short. 
Superoxide dismutase might still protect the neuro transmitter which was 
diffusing into the bath fluid and which was to be detected by the test tissues. If 
this was the case superoxide dismutase should result in the successful detection 
of the neurotransmitter release. Unfortunately there was neither an inhibitory 
response detected in the test tissues of the BRP, rat anococcygeus or rabbit aorta 
nor potentiation of the NANC response in the donor BRP in the presence of 
superoxide dismutase at concentrations from 100 u./ml. up to 200 u./ml.
As well as representing failure in the first objective of the present research, these 
results suggest that inactivation of the NANC neuro transmitter is unlikely to be 
by superoxide anion or heavy metal ions and it is unlikely that EDRF is the 
NANC inhibitory neuro transmitter in the BRP.
In bioassay experiments at necessary high sensitivity it is easy to produce 
artefact relaxation of the test tissues ( Fig. 17 ). For example the stimulating 
current applied to the donor tissue may escape and stimulate inhibitory nerves in 
the test tissues. Electrodes of a non-reversible type ( platinum ) may cause elec­
trolysis of the saline with the release of chlorine which is a powerful relaxant. 
The mechanical movement of the donor tissue if in same bath as the test tissues 
may be transmitted as a component of the response in the test tissues, especially 
since the recording sensitivity of the later is very high. Examples of all these 
were seen during this work. Escape of current will produce a relaxation simul­
taneous with the response in the donor tissue whereas if it was due to the release 
of neurotransmitter we might expect a delay between the response in the donor 
and that in the test tissue. The problem can be avoided by using a test tissue
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such as the rabbit aortic strip which does not possess NANC inhibitory nerves 
though this brings with it the problem of knowing whether its smooth muscle is 
sensitive to the NANC neuro transmitter. The problem can also be detected by 
removing the donor tissue but leaving the electrodes and repeating stimulation in 
the absence of the donor tissue. If the response is due to current escape, this will 
still take place and the test tissues respond. Reversible Ag/AgCl electrodes will 
eliminate the problem of electrolysis and a judicious rearrangement of the 
threads to the transducers can diminish or eliminate the transfer of mechanical 
movement from the donor to the test tissues. When all of these precautions were 
taken, no evidence of a humourally transferable neurotransmitter was found.
These experiments were carried out before the results of L-monomethyl-N- 
arginine ( L-NMMA ) and its reversal by L-arginine in the rat anococcygeus 
were known, results which suggest nitric oxide might be the neurotransmitter in 
the rat anococcygeus but not the BRP. Clearly it would have been better to use 
the anococcygeus, especially in the experiments with superoxide dismutase. If 
time had been available this would have been done .
THE EFFECT OF L-ARGININE ON THE NANC INHIBITORY RELAXA­
TION IN THE BRP MUSCLE
The second approach to identify the NANC inhibitory neurotransmitter was to 
study the effect of some drugs known to potentiate or block endothelium-derived 
relaxation in the hope of demonstrating some features in common between 
EDRF and NANC neurotransmitter. These substances were L-arginine, L- 
monomethyl-N-arginine and L-canavanine.
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In the BRP many substances were rejected as the NANC neurotransmitter. These 
substances are acetylcholine, adrenalin, noradrenaline, isoprenaline, histamine, 5- 
HT, a prostaglandin or any of the nucleosides, nucleotides or amino acid ( 
Klinge & Sjostrand 1974 ). Although the NANC inhibitory neurotransmitter is 
still unknown, many properties of this neurotransmitter have been reported such 
as its block by haemoglobin and methylene blue, and potentiation by M & B 
22948, a selective inhibitor of cyclic GMP phosphodiesterase ( Bowman & 
Drummond 1984; Bowman et al. 1986 ).
Palmer et al. ( 1987 ) reported experimental evidence that the EDRF was almost 
certainly nitric oxide. They studied the release of EDRF from the endothelial 
cells in culture and showed not only the ability to detect EDRF by bioassay but 
that it could also be detected by chemiluminescence technique which was rela­
tively specific for nitric oxide. Furthermore the chemical measurement was 
sufficient to account for the biological activity i.e. bioassay and chemical assay 
were in agreement. Nitric oxide itself caused relaxation indistinguishable from 
that induced by EDRF. Both substances were equally unstable. Bradykinin 
caused concentration-dependent release of nitric oxide from the cells in amounts 
sufficient to account for the biological activity of EDRF. The relaxation induced 
by EDRF and nitric oxide were inhibited by haemoglobin and enhanced by 
superoxide dismutase to a similar degree. They believed EDRF and nitric oxide 
were identical. In a more recent report ( Palmer et al. 1988a ) they identified L- 
arginine as the precursor of the nitric oxide. The evidence for this was that the 
release of nitric oxide from the endothelial cells cultured in the absence of L- 
arginine by bradykinin or the calcium ionophore A23187 was reversibly 
enhanced by infusions of L-arginine but not by its stereo-isomer D-arginine. 
Mass spectrometry studies using l5N -labelled L-arginine indicated this
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enhancement was due to the formation of nitric oxide from the terminal guani- 
dino nitrogen atom(s) of L-arginine. The strict substrate specificity of this reac­
tion suggests that L-arginine is the precursor for nitric oxide synthesis in vascu­
lar endothelial cells.
Since the NANC inhibitory neurotransmitter like EDRF owes its relaxant action 
to stimulation of soluble guanylate cyclase and the consequent elevation of cyclic 
GMP ( Diamond & Chu 1983; Furchgott & Jothianandon 1983; Rapoport & 
Muir 1983a; 1983b ) and both actions are blocked by methylene blue and hae­
moglobin and potentiated by M & B 22948 ( Gruetter et al. 1981a; 1981b; Bow­
man & Gillespie 1981; Martin et al. 1985; 1986 ), it seemed worthwhile to test 
the effect of L-arginine on the NANC inhibitory response.
In the fresh BRP L-arginine had no effect on the NANC inhibitory neuro­
transmission ( Fig. 20 & Fig. 22 ) although concentrations of L-arginine up to 
3x10"^. were used. These concentrations compare with an EC so of 3.5 +/- 0.1 
pM. for potentiation of the release of EDRF from vascular endothelial cells ( 
Palmer et al. 1988a ). It was possible, indeed likely, that the fresh BRP tissue 
contained sufficient stores of arginine to support many response to nerve stimula­
tion especially using short trains of 20 pulses. In the experiments with cultured 
endothelial cells reported by Palmer et al. ( 1988a ) the cells were washed three 
times and cultured in fresh culture medium without L-arginine for a further 24 
hours. If the cells were cultured in a medium containing L-arginine, there was no 
enhancement on the nitric oxide release in 11 out 16 experiments. Nevertheless 
attempts to deplete the BRP of arginine either by long stimulation trains or by 
storing in arginine-free Tyrodes for up to ten days were ineffective in demon­
strating a potentiation by L-arginine of the response even though by the sixth
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day of storage this was significantly smaller than the response in fresh controls. 
There are various explanations for this failure. The obvious one and the one 
accepted at the time was that arginine was not a precursor of the neuro­
transmitter. This still remains a likely possibility. The later finding with L- 
NMMA in the rat anococcygeus suggested quite strongly that it was a precursor 
in that tissue and the two preparations are so comparable that it is unappealing to 
believe they use different neurotransmitter. Alternative possibilities are that none 
of the procedures aimed at lowering arginine level were sufficiently effective to 
lower it below the level for neurotransmitter synthesis or that in the BRP L- 
arginine is not the sole precursor of nitric oxide. In favour of either of these 
hypotheses was the observation that in cold stored preparations L-arginine did 
often shift the dose-response curve to the left i.e. potentiate though the degree of 
shift was not statistically significant ( Fig. 35 to Fig. 38 ). Certainly the progres­
sive decline in response to NANC nerve stimulation in cold stored tissue after 
the fifth day was not due to a fall in postsynaptic sensitivity to nitric oxide since 
the response to sodium nitrite was well maintained ( Fig. 40 ).
In ability of the BRP muscle to maintain complete relaxation over long periods 
of stimulation without any exhaustion is consistent with its role in reproduction. 
In animals with a sheathed and retracted penis relaxation of the retractor penis is 
essential as well as engorgement of the erectile tissue. Also in these experiments 
many preparations produced about 80 -90 % relaxation of the raised tone to only 
one pulse of field stimulation further supporting the importance of the relaxation 
of the retractor penis in the productive function and the high capability of BRP 
to produce relaxation. When the stimulation of the BRP was stopped, the rapid 
restoration of the BRP original tone ( Fig. 24 ) might be also very important for 
the reproductive function because the sudden withdraw of the penis by the
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contraction of retractor penis is important to protect the penis from damage after 
ejaculation. These might be the special properties of retractor penis and its 
NANC innervation.
THE EFFECT OF L-NMMA AND L-CANAVANINE ON THE NANC INHIBI­
TORY NEUROTRANSMISSION IN THE BRP AND THE RAT ANOCOC­
CYGEUS MUSCLE
The evidence for L-arginine as the precursor of nitric oxide in endothelial cells 
has been given. Macrophages are other cells which also possess the ability to 
synthesize nitric oxide which is converted to nitrite and nitrate ( Iyengar et al. 
1987 ). This biosynthesis is L-arginine-dependent and the nitrogen of the nitric 
oxide like the nitrogen of EDRF is derived from the terminal guanidino nitrogens 
of L-arginine. No other amino acid nor ammonia could substitute for L-arginine 
except L-arginyl-L-aspartate. L-Canavanine ( 2 mM. ), a guanidinooxy structural 
analogue of arginine which inhibits the various L-arginine-utilizing enzymes, 
inhibited the formation of these NO-containing compounds when the macrophage 
was preincubated with L-canavanine for 12 hours.
If L-arginine is enzymatically converted to nitric oxide then inhibition of this 
conversion should block the formation and therefore the response. Two sub­
stances related chemically to arginine have been reported to do this. The first is 
L - m o n o m e thy 1-N-arginine ( L-NMMA ). Moncada and his group ( Palmer et al. 
1988b ) have reported that L-NMMA can inhibit the release of nitric oxide by 
bradykinin in cultured endothelial cells and the response to EDRF released by
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acetylcholine in rabbit aortic strip preparations. These effects are not showed by 
its D-isomer and are therefore stereospecific and the inhibition by L-NMMA can 
be competitively reversed by L-arginine i.e. it is an example of substrate com­
petition ( Palmer et al. 1988b ). In the present experiments we have confirmed 
this stereospecific inhibition of the EDRF response in rabbit aortic strips together 
with its reversion by L-arginine ( Fig. 54 ). The second substance is L- 
canavanine. In 1988 Schmidt et al. ( 1988a; 1988b ) also reported the attenuation 
of the endothelium-dependent relaxation of rat thoracic aorta rings induced by 
ATP and acetylcholine after the rings were pretreated with L-canavanine ( 2 
mM. ) for two hours. ATP dose-dependently stimulated the release of nitric 
oxide as detected by chemiluminescence. L-Canavanine abolished both basal and 
ATP-induced nitric oxide release.
If nitric oxide is the neurotransmitter of the NANC nerves and its origin is a 
similar enzymatic synthesis from L-arginine then L-NMMA and L-canavanine 
should inhibit the response. This was tested first in the BRP and in concentra­
tions up to 3x10"%!. did not inhibit the NANC inhibitory relaxation ( Fig. 42 & 
Fig. 43 ). Later when its effectiveness in inhibiting the response in the rat ano­
coccygeus was demonstrated the BRP was reexamined with higher concentration 
of 10_3M. L-NMMA and some inhibition of the response and a rise in the tone 
were observed ( Fig. 43 & Fig. 44 ). L-Canavanine gave similar results i.e. no 
inhibitory effect up to SxKTM. ( Fig. 55 & Fig. 56 ) but some reduction in the 
response at 10"3M. which was partially reversed by L-arginine ( Fig. 57 & Fig. 
58 ). These results are difficult to interpret. In the absence of a positive result in 
the rat anococcygeus by L-canavanine, the high concentrations of both L-NMMA 
and L-canavanine needed and the small inhibition observed in the BRP muscle 
might suggest the effects could be ignored as non-specific. Reinforcing this is the
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observation that the evidence for L-arginine involvement is most convincing in 
the anococcygeus where L-NMMA is a most effective blocking drug yet in that 
tissue L-canavanine is without effect. The similar efficiency of both drugs in the 
BRP at such high concentrations suggests a non-specific effect. Against that is 
the ability of L-arginine to produce some reversal of inhibition. It may be that in 
the BRP the enzymes involved in synthesis differ from those in the anococ­
cygeus and are more resistant to inhibition and alternatively there is more than 
one precursor and L-arginine plays only a part in the synthesis.
The effect of L-NMMA on the rat anococcygeus was dramatic. In a dose related 
fashion L-NMMA both raised the guanethidine-induced tone ( Fig. 47; Fig. 48 
& Fig. 50 ) and at the same level inhibited the NANC inhibitory relaxation to 
field stimulation ( Fig. 45 & Fig. 46 ). These effects were easily reversed by 
washing out the L-NMMA ( Fig. 47 ) or by L-arginine dose-dependently ( Fig. 
50 & Fig. 51 ) and prevented by L-arginine added with L-NMMA simultane­
ously ( Fig. 52 & Fig. 53 ). The D-isomer of L-NMMA was without effects on 
either tone or the response to NANC stimulation. Since the postsynaptic sensi­
tivity to nitric oxide was unaffected by L-NMMA, these results suggest the 
NANC inhibitory neurotransmitter is synthesized from L-arginine by L-arginine- 
utilizing enzymes and L-arginine is a major physiological precursor of the 
NANC inhibitory neurotransmitter in this muscle.
Given the effectiveness of L-NMMA, it was surprising to find that L-Canavanine 
was without effect on either tone or the NANC response in the rat anococcygeus 
in doses even higher than those inhibiting the BRP. This difference may be due 
to either a tissue difference or a species difference if one assures that the inhibi­
tory effect of high dose ( 10~3M. ) of L-canavanine on the BRP is selective. It
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may however be that L-canavanine is effective on the enzymes responsible for 
nitric oxide synthesis in macrophages but is not effective on the enzymes of 
either the endothelial cells or the NANC nerves. This is in spite of the reports 
by Schmidt et al. ( 1988a; 1988b ) that L-canavanine does significantly inhibit 
endothelium-dependent relaxation in rat aortic rings, in my own experiments L- 
canavanine in concentrations up to 2xiO_3M. for one hour had no effect on the 
response to EDRF released by acetylcholine in the rabbit aortic ring. If this is so 
then the only results which have a significance bearing on NANC neuro­
transmission are those with L-NMMA inhibiting the response in the rat anococ-
i
cygeus. The inhibition at high concentrations of L-NMMA in the BRP may not 
be specific. The explanation for the difference between the two muscles is not 
known.
It is unlikely that the failure of L-canavanine to inhibit the NANC response in 
the rat anococcygeus is due to a species difference since the report that L- 
canavanine inhibited endothelium-dependent relaxation in aortic rings was in the 
same species, the rat. But in our experiments L-canavanine had no effect on the 
endothelium-dependent relaxation induced by acetylcholine at concentrations 
from 3x10_5M. up to 2xiO'3M. for one hour’s pretreatment on the rabbit aortic 
strips ( unreported ). The very clear differences between the BRP and the rat 
anococcygeus in their sensitivity to L-NMMA could have several explanations. 
First the inhibitory neurotransmitter in both is the same, this explains the similar 
sensitivity to block by haemoglobin, but the precausor is not the same, only in 
the anococcygeus is L-arginine as essential precursor. Secondly the NANC inhi­
bitory neurotransmitter and its precursor may be the same in both muscles but 
the enzymes which synthesize the neurotransmitter are not identical and have 
different sensitivities to L-NMMA and L-canavanine. Thirdly the NANC
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inhibitory neurotransmitter might be different in the two muscles. This third 
hypothesis is unattractive since so many properties of NANC inhibitory neuro­
transmission are identical in the two tissues, their anatomical origins and function 
so similar and the effects of drugs such as haemoglobin and methylene blue on 
the NANC response identical. Resolution of the problem will require further 
work for example isolation of the enzymes responsible in the two tissues or 
perhaps study of nitrite formation from 15N labelled precursors during nerve 
stimulation.
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CONCLUSIONS
1. It has proved impossible to detect NANC inhibitory neurotransmitter in the 
BRP by bioassay.
2. L-Arginine does not potentiate the NANC nerve response in the fresh BRP 
tissues. Attempts to deplete endogenous arginine by either prolonged nerve 
stimulation or cold storage in an arginine free saline and uncover a poten­
tiating effect of L-arginine were unsuccessful.
3. L-monomethyl-N-arginine ( L-NMMA ) inhibits the NANC response in the 
rat anococcygeus in a dose related fashion between 10-5M. and 3x10“^ .  At 
these doses L-NMMA has no effect on the BRP. The effect on the anococ­
cygeus is stereospecific and competitively reversed by L-arginine. These 
results suggest L-arginine is the main precursor of the NANC inhibitory 
neurotransmitter in the rat anococcygeus but not in the BRP.
4. L-Canavanine has no effect on either muscle in concentrations up to 
3xl(r*M. At higher concentration of 10~3M. it produces some inhibition of 
the NANC response in the BRP but not in the rat anococcygeus. The effect 
of L-canavanine may be non-specific but if not then the enzymes involved 
in synthesis of nitric oxide in the two tissues may be different.
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5. The results though indirect favour nitric oxide on a substrate capable of 
liberating nitric oxide as neurotransmitter of the NANC nerves in the rat 
anococcygeus.
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THE EFFECT OF ARGININE AND L-N MONOMETHYL ARGININE ON THE RESPONSE 
OF THE BOVINE RETRACTOR PENIS TO STIMULATION OF ITS NANC NERVES
J.S. Gillespie & L. Xiaorong, Department of Pharmacology, Glasgow University. 
Glasgow, 012 8QQ.
Evidence suggests the EDRF is nitric oxide (NO) (Palmer fll.. 1987). More 
recently the same group have suggested its' precursor is the guanidino group 
of arginine (Palmer &1., 1988). This last suggestion is based on the
ability of arginine to increase the release of NO from cultured endothelial 
cells by bradykinin as measured both chemically and by bioassay. An even more 
recent reprint (Garthvaite ££ £lL. , 1988) suggests cerebellar nerve cells may 
release EDRF through activation of N-methyl-D-aspartate receptors.
In the bovine retractor penis (BRP) the response to EDRF, to NO and to a 
smooth muscle inhibitory factor extracted from the tissue are similar 
(Gillespie and Sheng, 1988) and the response to NANC nerve stimulation and to 
EDRF have much in common (Gillespie, 1987) suggesting NO might be the 
neurotransmitter in these nerves. We have therefore tested the ability of 
arginine to increase and L-N monomethyl arginine (LNMMA) to block the response 
to field stimulation of the NANC nerves.
BRP's from the abattoir were cleaned and small, strips 2 cm by approximately 2 
mm in breadth removed and mounted in ring electrodes in 10 ml baths containing 
Krebs saline at 37 degrees centigrade and gassed with a mixture of 95% O 2 + 5% 
CO2 . Motor adrenergic nerves were -blocked and tone raised by the addition of 
guanethidine 1 0 ' Frequency-response curves in response to field 
stimulation of NANC nerves were then constructed before the addition and in 
the presence of L arginine. Arginine in concentrations up to 3 x 10*'•M did 
not potentiate the response. Attempts were made to.exhaust transmitter stores 
by long trains of stimulation before adding arginine. There was still no 
potentiation. Finally, in an attempt to deplete endogenous arginine 
preparations were kept in sterile Tyrodes' solution at 4 degrees centigrade 
for periods of up to ten days. The solution was changed daily to remove any 
arginine which might have leaked from the tissue. The responses of groups of 
tissue were studied at daily intervals from 1-10 days. Arginine did not 
potentiate responses at any time.
The effect of the blocking drug LNMMA was examined. It failed to inhibit the 
response to NANC nerve stimulation. As a control the effect of LMNA was 
examined or, the response of fresh rabbit aortic strips to EDRF released by 
acetylcholine. LNMMA efficiently inhibited this response.
These results suggest arginine is not the precursor of the NANC 
neurotransmitter in the BRP. They do not however apply to the rat 
anococcygeus where LNMMA selectively inhibits NANC relaxation.
Garthvaite, J.. Charles, S.L. & Chess-Williams, R. (1988) Nature, 336, pp 
385-388.
Gillespie. J.S. (1987) Proceedings of the X International Pharmacological 
Congress, 161-170, Elsevier, New York.
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